WO2010105197A2 - Non-contact optical system, computer-accessible medium and method for measuring at least one mechanical property of tissue using coherent speckle techniques(s) - Google Patents

Non-contact optical system, computer-accessible medium and method for measuring at least one mechanical property of tissue using coherent speckle techniques(s) Download PDF

Info

Publication number
WO2010105197A2
WO2010105197A2 PCT/US2010/027193 US2010027193W WO2010105197A2 WO 2010105197 A2 WO2010105197 A2 WO 2010105197A2 US 2010027193 W US2010027193 W US 2010027193W WO 2010105197 A2 WO2010105197 A2 WO 2010105197A2
Authority
WO
WIPO (PCT)
Prior art keywords
anatomical structure
exemplary
plaque
arrangement
coherent radiation
Prior art date
Application number
PCT/US2010/027193
Other languages
French (fr)
Other versions
WO2010105197A3 (en
Inventor
Seemantini K. Nadkarni
Guillermo J. Tearney
Original Assignee
The General Hospital Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The General Hospital Corporation filed Critical The General Hospital Corporation
Priority to US13/256,175 priority Critical patent/US9351642B2/en
Publication of WO2010105197A2 publication Critical patent/WO2010105197A2/en
Publication of WO2010105197A3 publication Critical patent/WO2010105197A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0062Arrangements for scanning
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/02007Evaluating blood vessel condition, e.g. elasticity, compliance

Definitions

  • Exemplary embodiments of the present disclosure relates generally to measuring properties associated with tissues, and more particularly to non-contact optical system, computer-accessible medium and method for measuring at least one mechanical or material property of tissue using laser speckle.
  • thrombus mediated ischemic cardiovascular disease still remains the leading cause of mortality in industrialized societies.
  • the rupture of unstable coronary atherosclerotic plaque frequently can precede a majority of ischemic cardiovascular events.
  • the mechanisms leading to plaque rupture can be multi- factorial involving a complex liaison between morphological, compositional, biochemical and biomechanical processes. Due to the cumulative effect of multiple factors, the mechanical stability of the plaque is compromised resulting in an elevated risk of rupture. It is believed that during atherosclerotic plaque progression, the intrinsic mechanical properties of the plaque are serially altered and the measurement of a metric to accurately evaluate intrinsic plaque mechanical properties provides a key determinant of plaque stability. This belief can be based on evidence that mechanical factors greatly influence plaque stability.
  • Hemodynamic forces affect wall shear stresses influencing plaque progression, susceptibility to plaque rupture and coronary thrombosis. 6 Finite element studies have suggested that rupture of the fibrous cap is greatly influenced by regions of high circumferential stress typically in the lateral cap shoulders. The morphology and mechanical properties of the atheroma can affect stress distributions, with plaque rupture frequently occurring in focal regions of high stress concentrations caused by large differences in intrinsic mechanical properties of the fibrous cap and lipid pool. The mechanical properties of the atheroma determine the extent of induced deformation or strain in response to an extrinsic load. Higher strains are measured in lipid rich regions of lower viscosity. Cyclic mechanical strain within the arterial wall affects macrophage gene expression and SMC proliferation. Histology studies have shown the localization of MMP-I in regions of high circumferential strain within plaques, suggesting that mechanical properties influence MMP release further weakening plaque structure contributing to a greater tendency towards plaque rupture.
  • IVUS elastography computes local strains in the arterial wall in response to intra-luminal pressure differentials using cross-correlation analysis and estimation of tissue velocity gradients.
  • Elastography approaches have been applied to OCT to potentially provide higher spatial resolution of strain estimation relative to IVUS.
  • FEA approaches can utilize computer- generated models based on OCT or IVUS cross-sections and estimates of tissue material properties for modeling intra-plaque stress/strain distributions. These techniques provide important information in that they enable the measurement of plaque response to a dynamic external loading environment, thus aiding the investigation of plaque instability.
  • the measurement of plaque viscoelasticity using these approaches is intractable, requiring a priori guesstimates of viscoelastic properties, and knowledge of microstructure and loading conditions to solve the inverse problem.
  • Viscoelasticity and Brownian Motion Tissue is viscoelastic in nature, exhibiting both solid and fluid like characteristics.
  • the mechanical properties of viscoelastic materials can be evaluated by measuring a quantity, termed the "viscoelastic modulus", which determines the strain induced in the material in response to an extrinsic load.
  • the viscoelastic modulus is measured using a mechanical rheometer, in which a material is loaded between two parallel plates, an oscillatory stress at frequency, ⁇ , is applied and the a strain response is measured to evaluate viscoelasticity.
  • the real part, G'( ⁇ ) is the elastic modulus which defines the elastic solid like characteristics of the material and is the ratio of the elastic component of the oscillatory stress which is in phase with the strain.
  • the imaginary part, G"( ⁇ ) provides the viscous modulus and measures the out-of-phase response of the medium defining the material's fluid like characteristics.
  • the ratio between the elastic to viscous moduli provides a measure of 'phase', where a lower phase represents a more elastically dominated and a higher phase represents a more viscously dominated material.
  • Laser Speckle Imaging When an object is imaged using highly coherent light from a laser, a granular pattern of multiple bright and dark spots becomes apparent on the image, which bears no perceptible relationship to the macroscopic structure of the object.
  • These random intensity patterns termed as laser speckle, can occur in two situations: (i) when coherent light is reflected from a surface which is rough on the scale of an optical wavelength, and (ii) when coherent light propagates through and is scattered by a medium with random refractive index fluctuations such as in tissue.
  • the interference of light returning from the random surface or medium causes laser speckle.
  • Laser speckle formed from scattering within tissue isakily sensitive to Brownian motion.
  • the Brownian motion of endogenous light scattering particles in tissue causes scatterer locations and optical path lengths to dynamically change resulting in time dependent intensity modulations of laser speckle.
  • the rate of laser speckle modulation can be highly dependent on the extent of motion of suspended scatterers, which is in turn influenced by viscoelasticity of the medium. Consequently, in an atheroma, due to the relatively low viscosity of lipid, endogenous scatterers within the compliant necrotic core exhibit more rapid Brownian motion compared to the stiffer fibrous regions of the plaque. Since scatterer motion governs the modulation of laser speckle, the measurement of temporal intensity variations of laser speckle patterns provides information about the viscoelastic properties of the plaque.
  • the measurement of intensity modulations of time-varying laser speckle patterns can provide a highly sensitive technique for evaluating atherosclerotic plaques.
  • Exemplary procedures using excised atherosclerotic plaques have been reviewed, indicating that the measurement of intrinsic Brownian motion of endogenous particles, related to viscoelasticity, can be used to distinguish plaque type, and evaluate collagen and lipid content.
  • exemplary embodiments of the LSI techniques and systems according to the present disclosure can be provided for plaque characterization and identification of high-risk plaque
  • the exemplary LSI time constant can be related to collagen and lipid content
  • exemplary embodiments of the LSI techniques and systems according to the present disclosure can measure an index of viscoelasticity that can be related to the viscoelastic modulus, G*
  • fibrous cap thickness can be measured using LSI
  • exemplary embodiments of the LSI techniques and systems according to the present disclosure can identify high-risk plaques during physiological arterial deformation
  • the apoE knockout mouse can provide a useful model to evaluate plaque progression.
  • exemplary embodiments of LSI techniques and system can provide an exemplary platform for measuring composite metrics of plaque stability based on biomechanical, structural and compositional factors.
  • Exemplary measurements of time constant can be performed by fitting a single exponential to a portion of the normalized speckle decorrelation curve.
  • One of the objects of certain exemplary embodiments of the present disclosure is to provide quantitative indices based on plaque biomechanical properties using LSI to determine the risk of plaque rupture. While certain preliminary studies have successfully demonstrated the capability of LSI in diagnosing plaque type, in order to realize the exemplary objects of the present disclosure, the exemplary embodiment of the LSI techniques and systems can facilitate its use to accurately quantify plaque viscoelasticity. According to one exemplary embodiment of the present disclosure, it is possible to facilitate exemplary methods and systems for measuring the viscoelastic properties of arterial tissue from, e.g., laser speckle images and compare our results with standard mechanical testing measurements.
  • ⁇ Exemplary LSI techniques and systems can be implemented using a relatively inexpensive laser source and a high-speed CMOS or CCD camera, enabling the study of tissue viscoelastic behavior 'in situ' over a large frequency range over several kHz, defined by the frame rate of the detector.
  • ⁇ Exemplary LSI measurements can be sensitive to small changes in the viscoelastic properties of the tissue because speckle decorrelation induced by phase shifts in highly scattering media requires very minute displacements of scatterers at length scales smaller than the optical wavelength.
  • ⁇ Beam scanning enables the unique ability to measure 2D distributions of tissue viscoelastic behavior.
  • CMOS or CCD technology enables speckle decorrelation measurements over very short time scales (few ms) over which the influence of low frequency arterial deformations induced by cardiac (-1Hz) or respiratory (-0.2 Hz) motion is largely mitigated.
  • few ms very short time scales
  • ⁇ Exemplary LSI techniques and systems can be utilized implementing small-diameter optical fiber bundles, thus elegantly lending itself for intracoronary applications.
  • Exemplary embodiments of the LSI techniques and systems according to the present disclosure can be accurate for the detection of thin-cap fibroatheromas, and for measuring necrotic core area, fibrous cap thickness and plaque morphology ex vivo.
  • Exemplary LSI techniques and systems according to the present disclosure can be accurate for the detection of thin-cap fibroatheromas, and for measuring necrotic core area, fibrous cap thickness and plaque morphology ex vivo.
  • exemplary embodiments of apparatus and method for determining at least one material property of an anatomical structure can be provided.
  • a first arrangement it is possible to apply at least one first coherent radiation to at least one portion of the anatomical structure, and receive at least one second coherent radiation from such portion(s).
  • the first and second coherent radiations can be associated with one another.
  • Such determination can be performed without (i) any portion of an apparatus performing the procedure causing an induction of at least one mechanical deformation on or in the anatomical structure, and/or (ii) any mechanical deformation on or in the anatomical structure.
  • the first and/or second coherent radiation(s) can be an electro-magnetic radiation. It is possible to scan the anatomical structure at multiple locations, e.g., simultaneously and/or sequentially. It is also possible to detect a scan of the anatomical structure at the multiple locations simultaneously and/or sequentially.
  • the material property can be spatially-varying or depth-varying, as well as an elastic property or a viscous property of the anatomical structure. Further, the material property can be a macroscopic property, a microscopic property and/or a mesoscopic property of the anatomical structure. Such material property can also be a strain on the anatomical structure.
  • the material property as a function of frequencies of motion of scatterers within the anatomical structure.
  • the motion of the scatterers within the anatomical structure can be a Brownian motion.
  • the first coherent radiation can be a multiply-scattered light, a single-scattered light, and/or coherent speckle. It is also possible (e.g., using the first arrangement) to apply the first coherent radiation(s) to at least one portion in-vivo.
  • the first and/or second coherent radiation(s) can be an acoustic radiation.
  • Figure 1 is an exemplary illustration of speckle patterns acquired from a thin- cap fibroatheroma (TCFA) showing time-dependent fluctuation of laser speckle;
  • TCFA thin- cap fibroatheroma
  • Figure 2(A) is an exemplary graph of Speckle decorrelation curves obtained for three exemplary aortic specimens: TCFA, thick-cap fibroatheroma (TKFA), and fibrous aortic plaques;
  • Figure 2(B) is an exemplary chart illustrating mean ⁇ computed for different plaque groups under static conditions
  • Figure 3 is an exemplary graph illustrating G* measured using a rheometer in response to a oscillatory load at frequencies less than IHz;
  • Figure 4(A) is an exemplary graph of a spatial heterogeneity in ⁇ obtained by beam scanning over a necrotic core fibroatheroma
  • Figure 4(B) is an exemplary graph of the spatial heterogeneity in ⁇ obtained by beam scanning over a calcific plaque
  • Figure 4(C) is an exemplary graph of the spatial heterogeneity in ⁇ obtained by beam scanning over a fibrous plaque
  • Figure 4(D) is an exemplary map illustrating a distribution of speckle decorrelation time constants over a lesion compared with the accompanying gross pathology
  • Figure 5(A) is a graph of T (P) is plotted vs. distance p from source;
  • Figure 5(B) is an exemplary schematic illustration of a photon propagation through a two-layer model
  • Figure 6(A) is an exemplary block diagram of an exemplary embodiment of a method according to the present disclosure which can be used to measure and validate sample viscoelasticity using the exemplary LSI techniques;
  • Figure 6(A) is an exemplary block diagram of an exemplary embodiment of a system according to the present disclosure which can be used to measure and validate the sample viscoelasticity using the exemplary LSI techniques;
  • Figure 7(A) is an exemplary graph of frequency-dependent complex viscoelastic moduli measured from laser speckle patterns of fat, cartilage and skeletal muscle using the exemplary embodiments of the methods and systems according to the present disclosure
  • Figure 7(B) is an exemplary graph of frequency-dependent complex viscoelastic moduli measured from laser speckle patterns of calcific, fibrous and lipid-rich atherosclerotic plaques using the exemplary embodiments of the methods and systems according to the present disclosure
  • Figure 8(A) is an exemplary gross pathology photograph of a human aortic segment
  • Figure 8(B) is an exemplary map of the distribution of complex viscoelastic moduli measured at high frequency (-250 Hz) by scanning a focused beam over the human aortic sample shown in Figure 8(A);
  • Figure 8(C) is an exemplary map of the distribution of complex viscoelastic moduli measured at frequencies -100 Hz by scanning a focused beam over the human aortic sample shown in Figure 8(A);
  • Figure 8(D) is an exemplary map of the distribution of complex viscoelastic moduli measured at lower frequencies ⁇ 10 Hz by scanning a focused beam over the human aortic sample shown in Figure 8(A);
  • Figure 9 is an exemplary graph of the spatial variation of speckle decorrelation time constant over a mouse aorta with a fibrous plaque.
  • Measuring viscoelasticity of atherosclerotic plaques Characterization of Atherosclerotic Plaque using LSI: The exemplary capability of the exemplary embodiments of the LSI systems and methods according to the present disclosure for differentiating atherosclerotic plaque type, and assessing plaque morphology and composition is demonstrated has been described in, e.g., S. Nadkarni, et al., "Characterization of atherosclerotic plaques by laser speckle analysis", Circulation, 2005. In this publication, 118 aortic specimens were obtained from 14 human cadavers using LSI.
  • TCFA thin-cap fibroatheroma
  • TKFA thick-cap fibroatheroma
  • PIT pathological intimal thickening
  • FA non-necrotic fibroatheroma
  • IH intimal hyperplasia
  • FC fibrocalcific plaque
  • Figure 2(A) shows examples of the normalized speckle decorrelation curves computed for three aortic plaques.
  • the average exemplary speckle decorrelation time constant, ⁇ computed for different plaque groups under static conditions are plotted in Figure 2(B).
  • the results of the analysis of variance (ANOVA) and Dunnetts t- tests demonstrated highly significant differences in ⁇ between the plaque groups (p ⁇ 0.0001) .
  • TCFA's exhibited a significantly lower time constant ( ⁇ ⁇ 47ms) as compared to other lesions due to rapid Brownian motion of endogenous particles within the compliant necrotic core (p ⁇ 0.001) .
  • the exemplary LSI technique demonstrated high diagnostic sensitivity (100%) and specificity (92%) for identifying TCFA's. Fibrous and fibrocalcific lesions were also easily discriminated from lipid- containing lesions due to their significantly higher time constants.
  • the exemplary LSI technique was performed on type I collagen gels at varying concentrations (0.2%, 0.3%, 0.4%, 0.6% and 0.8% m/v), and on cartilage disks (type II collagen) obtained from swine knees and ears.
  • Mechanical testing can be performed on all gel and cartilage samples using a Bohlin C-VOR rheometer (Malvern Instruments Inc., MA) to measure G( ⁇ ), (0.5 ⁇ 10Hz).
  • Figure 3 shows a graph with exemplary mechanical measurements of viscoelastic moduli of collagen gels obtained using a rheometer.
  • Atherosclerotic plaque studies In another example, the exemplary LSI technique was conducted by averaging ⁇ values over 4mm disks of arterial sites, histologically confirmed as calcific, fibrous and NCFA. Mechanical testing was performed using the Bohlin rheometer, and the modulus, G, was measured by averaging G( ⁇ ) over the linear range.
  • the above exemplary results indicate a close relationship between LSI measurements of ⁇ and G( ⁇ ) measured by mechanical testing.
  • the atherosclerotic plaque can be modeled as a multilayered cylinder of thickness, L and viscoelastic modulus, G.
  • L thickness
  • G viscoelastic modulus
  • the assumption that G «G can be made', which can be supported by ex-vivo exemplary analysis above.
  • a NCFA can be considered, consisting of a fibrous cap layer of thickness Ll with modulus Gl , overlying lipid pool layer of thickness L2 with modulus G2, loaded between the parallel plates of a rheometer.
  • the twisting moment M applied by the rheometer can be determined by the distribution of shear stresses, T, integrated across the cylinder of cross-sectional area, A.
  • the moment, M is given by:
  • Equation (Cl) shows that the overall bulk viscoelastic modulus of the plaque is related to the thickness and viscoelastic modulus of each layer.
  • This exemplary model can be extended to include multiple layers of varying depth-dependent viscoelasticity by using the generalized equation:
  • Laser speckle to evaluate spatial (or transverse) heterogeneity Laser speckle images can be obtained by scanning the laser beam at small spatial increments and the spatial distribution of ⁇ can be measured across the plaque.
  • Figures 4(A)-4(D) illustrate the transverse spatial variation of ⁇ as a function of beam location. As the beam was scanned across each lesion, ⁇ varied significantly depending on tissue type: ⁇ was low (20 - 50 ms) in the necrotic core regions 405 (see graph 400 - shown in Figure 4(A)) and higher in the calcific 415 (-2200 ms as shown in graph 410 in Figure 4(B)) and fibrous 425 ( ⁇ 800ms as shown graph 420 in Figure 4(C)) regions.
  • Figure 4(D) illustrates a two-dimensional map 435 of the spatial distribution of ⁇ , measured by scanning the beam at 300 ⁇ m increments across a lipid-rich plaque: a well-demarcated region 430 of low ⁇ relative to the surrounding aortic tissue is seen.
  • beam scanning can be utilized to evaluate spatial variation in plaque viscoelasticity to potentially detect heterogeneities such as calcific nodules and localized necrotic cores.
  • Laser speckle to evaluate depth heterogeneity Due to the diffusive properties of light propagation in tissue, photons returning from deeper regions have a higher probability of remittance farther away from the illumination location.
  • While beam scanning can provide information about spatial heterogeneities, depth-dependent heterogeneities can be measured by analyzing variation in ⁇ as a function of radial distance, p, from the illumination location in each speckle image.
  • An exemplary embodiment of the method and system according to the present disclosure can be provided to obtain depth-dependent measurements by combining spatio-temporal laser speckle analysis with diffusion theory and Monte Carlo models of light propagation.
  • Such exemplary method and system can be used to measure fibrous cap thickness in necrotic-core fibroatheromas (NCFA's), which can also be applied to evaluate depth-dependent viscoelasticity.
  • NCFA's necrotic-core fibroatheromas
  • FIG. 5(A) shows a graph of ⁇ (p) plotted vs. distance p from source
  • Figure 5(B) shows an exemplary schematic illustration of a photon propagation through a two-layer model.
  • Figure 5(A) shows that ⁇ (p) is plotted vs. distance p from source.
  • An exemplary embodiment of the method, computer-accessible medium and system to measure viscoelastic properties of atherosclerotic plaques from laser speckle images can be based on previously-established optical methods. For example, using certain dynamic light scattering techniques, a quantity termed the mean square displacement (MSD),
  • ⁇ ' can be measured which provides an assessment of scatterer motion such as Brownian motion in the tissue.
  • the MSD can be related to the material's frequency- dependent viscoelastic modulus, ' ⁇ ' .
  • DWS Diffuse Wave Spectroscopy
  • a laser beam can be provided incident on the sample and light scattered multiple times is collected using a single optical fiber in transmission or backscattering geometry.
  • the time-varying intensity fluctuations over a single speckle spot can be measured by averaging over several cross-correlation functions that evolve in time to obtain the function, 02 ( U ⁇ can be used to measure the MSD and the resulting elastic, G ' ( ⁇ ) , and viscous, ( ⁇ ) , moduli and the resulting complex modulus ' ⁇ ' .
  • U ⁇ can be used to measure the MSD and the resulting elastic, G ' ( ⁇ ) , and viscous, ( ⁇ ) , moduli and the resulting complex modulus ' ⁇ ' .
  • LSI as used herein can be similar to the "multispeckle" DWS described in polymer rheology applications, but certainly not limited thereto.
  • the evaluation of two-dimensional speckle images e.g., in the exemplary LSI techniques and systems
  • a single speckle spot e.g., in standard DWS
  • the exemplary procedures of such methods to provide and validate the measurement of plaque viscoelasticity using the exemplary embodiments of the LSI techniques and systems according to the present disclosure is shown in the block diagram of Figure 6(A).
  • time varying laser speckle images can be acquired at high frames (block 610).
  • The, in block 920, such time-varying laser speckle images acquired at high frame rates can be analyzed using exemplary cross-correlation techniques to obtain the speckle decorrelation curve, 92 ") (block 620).
  • the MSD of particle motions such as Brownian motion can be estimated or measured from the speckle decorrelation data (block 630).
  • Parameters that characterize the medium scattering properties required to estimate the MSD can be evaluated from time-averaged laser speckle images (block 680) and by using diffusion theory and Monte Carlo simulations of light propagation through the sample (block 670).
  • the viscoelastic or complex modulus, ' ⁇ ' and the elastic, ' ⁇ ' and viscous, ' ⁇ ' moduli can be derived (block 640) and compared with standard mechanical testing measurements (block 650).
  • An exemplary embodiment of the LSI system according to the present invention can be provided to acquire laser speckle images, as shown in Figure 6(B).
  • light from an unpolarized Helium Neon light source 670 e.g., 632 nm, 30 mW
  • an optical fiber arrangement 675 such as a single-mode fiber.
  • the beam can be expanded by, e.g., 5: 1, reflected off a galvanometer-mounted mirror 680,and focused to, e.g., a 50 ⁇ m diameter spot on the surface of a sample 685.
  • the galvanometer-mounted mirror 680 can be computer-controlled by a computer 690 to facilitate scanning the illumination beam across the sample 685.
  • a collection arrangement 695 such as, e.g., a high-speed, digital CCD or CMOS camera (e.g., Mikrotron MC 1310) configured to acquire speckle patterns at high frame rates may be provided and images can be transferred to the computer 670 in real time. Time-varying cross polarized laser speckle images can be acquired from imaging sites on the tissue sample 685.
  • Exemplary Laser Speckle Image Analysis Measurement of mechanical properties such as viscoelastic moduli
  • Exemplary acquired time-varying laser speckle patterns can be analyzed using
  • the normalized 2D cross-correlation of the first speckle image with each image in the time- varying image series can be determined using the exemplary embodiments of the present disclosure.
  • the maximum value of normalized cross-correlation can be determined and
  • the 92 O curve can be evaluated to obtain the MSD and the resulting elastic, viscous and complex moduli.
  • the ensemble speckle cross-correlation function, 02 ( f/ 5 can t> e expressed in terms of the MSD,
  • the mean free path, / * can characterize the scattering medium and is defined as the distance a photon travels before its direction is completely randomized.
  • G * ( ⁇ ) is the frequency dependent complex viscoelastic modulus
  • a is the scatterer
  • the particle size, a is the characteristic length scale probed and can be given by,
  • Average particle sizes of different tissue types can also be estimated using an iterative process by ' ⁇ ' using a mechanical rheometer, and retrospectively deducing particle size, a, values using equation (D2). This a priori estimate of particle size can then be applied to measure viscoelastic properties from laser speckle patterns for prospective measurements of tissue samples.
  • the elastic, ' ⁇ ' , and viscous, ( ⁇ ) , moduli can be determined using the following relations:
  • G'( ⁇ ) ⁇ G * ( ⁇ ) ⁇ cos( ⁇ a( ⁇ ) / 2)
  • G" ( ⁇ ) ⁇ G * ( ⁇ ) ⁇ sin( ⁇ a( ⁇ ) 12)
  • the exemplary evaluation of the MSD techniques of probe particles from the g ⁇ ft) function as expressed in equation (Dl) can utilize the measurement of the distribution of photon trajectories, P(s) , traversing a path length s, and the mean free path, / * .
  • the parameters, P(s) and / * which characterize the optical properties of scattering medium can be derived from time-averaged speckle images using previously described methods. It is possible to determine optical properties of human tissue by combining a diffusion theory model of spatially-resolved diffuse reflectance 58 and a Monte-Carlo model of light transport in tissue.
  • the optical properties of the sample by measuring the radially dependent remittance from the sample. Apriori estimates of tissue optical properties can also be used.
  • Time-varying speckle images of the fibrous plaque can be obtained using the imaging the exemplary embodiment of the system and method according to the present disclosure as described herein.
  • the total number of diffuse photons remitted from the plaque and detected by the CCD sensor can be measured by time-averaging speckle images acquired over a time duration of a few seconds or longer.
  • the radially-resolved photon probability, 'P) for the fibrous plaque can be generated by summing the number of photons detected over different annuli of radii P , and then normalizing this value by the total number of photons detected over the area of the detector.
  • the theoretical radial photon probabilities determined from a single- scatterer diffusion model for the case of a semi-infinite homogeneous tissue58 can be fitted to the measured radial photon probabilities, " 'P ) , using a least-square optimization procedure, to extract the optical properties, ⁇ a , ⁇ s and ⁇ , of the sample.
  • the mean free path, / * can be then evaluated for the scattering medium, which is given by ⁇ ' Va '' ' Vs ) .
  • Photon initial conditions can include input beams perpendicular to the semi-infinite layer. Multiple runs can be performed with the same set of optical properties and photon packet trajectories can be launched. Remitted photons can be collected over a radial distance of a few mm. From the output of the Monte Carlo simulations, the maximum path length, s, traversed by each photon can be recorded and the path length distribution, ' s ) , of photons can be measured. The parameters, ' s ' and / * , can be input into equation Dl to determine the MSD of probe Brownian motion in the sample. Exemplary Methods
  • Exemplary LSI system optics Optics for light delivery and speckle image transmission can be designed and optimized using, e.g., ZEMAX (ZEMAX Development Corporation). A variety of different lenses can be simulated and optimization can be performed to minimize aberrations through different optical window designs and to increase field of view. Following the optimized design and selection of configuration and components, optical elements can be obtained.
  • the laser, illumination and collection optics, optical fibers, CCD camera, galvanometer-controlled mirror, linear translation device, and computer can be integrated in a portable cart.
  • Software can control the motors, reading and storing motor encoder positions, laser speckle analysis, and displaying data in a various formats for ease of interpretation.
  • Type I collagen can be a predominant constituent of the extracellular matrix in atherosclerotic plaques
  • test phantoms can be made using commercially available collagen to evaluate the performance of LSI in measuring sample viscoelasticity.
  • Collagen gels (Type I) can be constructed from rat tail tendon collagen dissolved in 0.02N acetic acid (8mg/ml) (BD Biosciences, catalog no. 354249). Latex microspheres with a diameter of about 0.3 ⁇ m (10% in water) can be used as light scattering probes.
  • collagen gels can be constructed with at each collagen concentration of 0.7%, 0.5%, 0.3%, 0.2%, and 0.1% (mass/volume).
  • a high pH buffer can be used to neutralize the acetic acid in the collagen solution.
  • a high pH buffer can be used.
  • Cadaveric coronary arterial segments can be excised during autopsy, and slit longitudinally open to expose the luminal surface.
  • the coronary segments can be immersed in phosphate buffered saline and warmed to 37°C before imaging.
  • Time-varying laser speckle images of the coronary arterial specimens and collagen gel phantoms can be obtained over a measurement duration of about I s, according to one exemplary embodiment of the present disclosure.
  • each sample can be stabilized on a cork-board, clamped onto an L-brackets mounted on a linear motorized stages.
  • the L-brackets can be immersed in a PBS bath maintained at about 37°C such that the luminal surface of the artery (or surface of the collagen gel) is exposed just above the level of PBS.
  • time-varying laser speckle images can be obtained at randomly selected discrete lesion sites along the segment.
  • Each imaging site can be marked with two India ink spots marking the diameter of the speckle pattern over the lesion, to facilitate accurate registration with mechanical testing measurements and histopathology.
  • Circular sections can be cut across the artery at each marked imaging site using a 1mm circular punch biopsy too and stored in, e.g., PBS.
  • laser speckle images can be obtained three randomly selected sites for each gel to evaluate heterogeneity.
  • the frequency-dependent viscoelastic modulus, G * ( ⁇ ) can be computed at each spatial location from the time-varying laser speckle images using techniques described above. Following LSI, the samples can be prepared for standard mechanical testing procedures.
  • Mechanical testing to measure the viscoelastic properties of the coronary arterial specimens and collagen gel phantoms can be performed using a Bohlin C-VOR computer-controlled mechanical rheometer (e.g., Malvern Instruments, Southborough, MA).
  • An exemplary embodiment of the system according to the present disclosure can include two parallel plates that can hold the sample affixed to the bottom plate to prevent slipping.
  • a shear stress can be delivered to the sample by the motor via an oscillatory torque applied to the top plate.
  • the resultant strain in the sample can be measured by an angular position sensor incorporated in the exemplary system and automated Bohlin system software can calculate G * ( ⁇ ) , G'( ⁇ ) and G"( ⁇ ) .
  • the mechanical testing can be conducted at, e.g., about 37 0 C. In the first stage of mechanical testing, a gradually increasing stress can be applied and the strain response can be recorded.
  • the resultant viscoelastic modulus, G * can be plotted as a function of measured strain to determine the range of linear strain response over which G * is independent of strain to provide an estimate of the mechanical strength of each sample.
  • the threshold strain, ⁇ ma ⁇ can be determined above which the sample's intermolecular forces are overcome by the stress and the sample viscoelastic modulus falls.
  • an oscillatory strain can be induced in the sample swept through a frequency range, 1 ⁇ ⁇ ⁇ 100 Hz .
  • the maximum strain can be maintained at ⁇ ma ⁇ .
  • the frequency dependent viscoelastic, G * ( ⁇ ) , elastic, G'( ⁇ ) and viscous, G"( ⁇ ) , modulii can be recorded for each sample.
  • Exemplary LSI measurements of viscoelastic moduli performed in the coronary specimens and collagen gel phantoms can be compared with mechanical testing and Histological measurements of plaque collagen content. Exemplary results are shown below: [0077]
  • the overall "macro" viscoelastic modulus of bulk tissue within the illuminated volume can be measured from the MSD data determined over the entire speckle pattern obtained by focusing the beam to a 50 ⁇ m spot.
  • Figure 7A illustrates the bulk viscoelastic moduli measurements plotted as a function of frequency measured from laser speckle patterns of cartilage 700, skeletal muscle 705, and adipose fat at temperatures of 4°C 710 and 40 0 C 715.
  • the exemplary results indicate that cartilage 700 has highest modulus values compared to skeletal muscle 705 and adipose fat 710, 715. Additionally, temperature influences sample viscoelasticity evidenced here by a lower modulus measured for adipose fat at 40 0 C 715 compared to that at 4 0 C 710.
  • Figure 7B shows the exemplary LSI measurements of plaque viscoelasticity obtained from human atherosclerotic plaques. The results demonstrate that higher moduli measurements were measured for the calcific plaques 720 and fibrous plaques 725 compared to the lipid-rich plaque 730. At higher frequency regions of the
  • Viscoelasticity mapping While laser speckle patterns obtained by beam focusing (as described above) can provide information about tissue viscoelasticity over the illuminated volume, scanning a collimated or focused beam over a sample can facilitate the evaluation of spatial heterogeneities in viscoelastic moduli.
  • Figures 8(A)-8(D) show an example of two-dimensional maps of the frequency dependent modulus, G( ⁇ ) , measured by scanning a 5mm collimated beam over a 5cm region of a human cadaveric artery. In this case, G( ⁇ ) values were computed from MSD data measured within overlapping windowed regions of 100 x 100 ⁇ m over the artery.
  • Two-dimensional maps of G( ⁇ ) can be obtained by performing an interpolation over the region of interest.
  • G( ⁇ ) maps computed at different frequencies are plotted, respectively, and compared with a gross pathology photograph ( Figure 8(A)) of the artery, in which calcific regions 800, fibrous regions 805 and lipid-rich regions 810 are demarcated.
  • the India ink spot 815 is also visible in the maps, and can used for accurate registration of the G( ⁇ ) maps with the gross pathology image.
  • the calcific tissue types 820, fibrous tissue types 825 and lipid-rich tissue types 830 are distinguished by significant differences in their viscoelastic moduli.
  • tissue viscoelastic moduli over a varying range of scales (microscopic, mesoscopic and macroscopic).
  • Exemplary method to monitor changes in tissue mechanical properties during disease progression changes in arterial viscoelastic properties using LSI during plaque progression in a mouse model of atherosclerosis
  • Exemplary Monitoring changes in arterial viscoelasticity during plaque progression It is possible to use the exemplary methods according to the present disclosure as described herein above to monitor arterial viscoelastic moduli during different stages of atherosclerosis progression in a murine model. For example, it is possible to evaluate the influence of multiple factors on the arterial viscoelasticity specifically: stage of atherogenesis (imaging time point), plaque type and blood cholesterol. Mice on a high fat diet can be investigated at four imaging time points. LSI of murine aortic, brachiocephalic, carotid arteries and the iliac bifurcation can be conducted. Time-varying laser speckle images can be analyzed to measure arterial viscoelastic moduli. Arterial viscoelasticity can be serially monitored at each imaging time point and compared with Histopathological findings at sacrifice.
  • Atherosclerotic mouse model using Apolipoprotein E knockout (ApoE -/-) mice (background strain - C57BL/6) can be used to review this exemplary embodiment.
  • This exemplary model can be based on previous analyses which indicated that advanced necrotic core plaques resulting in plaque rupture occurred in apoE-knockout mice after 8 weeks of fat feeding.
  • the exemplary LSI analyses can be implemented to (i) evaluate the use of apo E-/- mice to evaluate plaque progression, and (ii) to test the feasibility of measuring viscoelasticity of mouse arteries using laser speckle techniques.
  • the apolipoprotein E knockout (ApoE -/-) murine model has been shown to be a reliable and reproducible model for atherosclerosis, and its lesion characteristics are similar to those associated with plaque instability in humans.
  • the feasibility of measuring arterial viscoelasticity of aortic plaques can be assessed in apo E-/- mouse arteries.
  • segments of the abdominal aorta were obtained from a fat fed apo E-/- mouse at 14 weeks.
  • an exemplary LSI procedure was conducted by scanning a focused (20 ⁇ m) beam (632nm) and measuring ⁇ , at 300 ⁇ m increments along the length of the aorta.
  • Figure 9 shows the spatial distribution of ⁇ 900 co-registered with the corresponding gross pathology photograph of the mouse aorta 905, and measured by beam scanning which shows evidence of fibrous plaque with varying mechanical properties.
  • Lower ⁇ values adjacent to the fibrous plaque may be attributed to hyperlipidemia in the apo E-/- mouse.
  • This exemplary data indicates that by beam focusing in conjunction with scanning, the exemplary LSI technique and system according to the present disclosure can detect plaques in mouse arteries
  • mice can be used; for example, 48 C57BL/6 ApoE -/- and 12 regular
  • C57BL/6 mice can be studied.
  • the 48 ApoE -/- mice can be placed on a high fat diet (e.g., 0.2% cholesterol, 21% fat, Harlan Tekland #88137) and 12 control mice continued on a regular chow diet (0% cholesterol, 5.7% fat, Harlan Tekland #2018).
  • the first imaging time point can be at 6 weeks after initiation of the high fat diet.
  • 12 ApoE -/- and 3 control mice can be randomly selected and sacrificed.
  • the mouse vasculature can be prepared for imaging and LSI measurements along with corresponding Histopathology can be performed on each animal (as described below).
  • the second, third and forth imaging time point can be, e.g., at 12 weeks, 18 weeks and 24 weeks after initiation of the high fat diet.
  • LSI and Histopathological measurements can proceed in the manner described for the first imaging time point.
  • blood samples can be drawn from both ApoE -/- and control mice, and total cholesterol can be determined enzymatically.
  • the exemplary sites of lesion prediliction in the apoE -/- mouse aorta are shown in Figure 9.
  • brachiocephalic trunk, and the left and right common carotid arteries can be imaged in 1 mm increments advancing from the aortic arch towards the carotid bifurcation.
  • Time-varying laser speckle images can be obtained at high frame rates at each imaging site over a measurement time duration determined using the exemplary embodiments described herein above.
  • the arterial segments can be fixed in about 10% formalin, embedded and sectioned using standard Histology techniques.
  • the sections can be stained with H & E and Trichrome stains, and interpreted by a pathologist blinded to the LSI data.
  • Atherosclerotic lesions and the natural history of their progression in the apoE-knockout mouse bear a resemblance to atherogenesis in humans. Fatty streaks are present in early stages and as lesions progress multilayered appearances occur showing presence of smooth muscle cells.
  • Advanced lesions indicated fibrous cap appearance, necrotic core, cholesterol clefts and calcifications.
  • Spontaneous plaque rupture has been shown in fat fed mice with the fibrous cap significantly thinner in ruptured lesions than intact lesions. Due to the similarities with human atherosclerosis, it is possible to characterize atherosclerotic lesions in apoE-knockout mice based on the classification scheme proposed by Virmani et al. Atherosclerotic lesions can be classified into the following six groups: intimal xanthoma (or fatty streak), intimal thickening (IT), necrotic core fibroatheroma (NCFA), ruptured plaque, fibrous plaque and calcific plaque.
  • Exemplary time-varying laser speckle images obtained from the mouse vasculature can be evaluated using the exemplary techniques described herein above.
  • the frequency dependent viscoelastic modulus, G * ( ⁇ ) can be measured from the mean square displacement of plaque particles which will determined from the speckle cross correlation curve, g ⁇ ft) -
  • the value of the viscoelastic modulus, G * at the optimal frequency, ⁇ (as described herein above) can be recorded from the G * ( ⁇ ) data. Bas ed on histological diagnoses, the G * value associated with each lesion can be assigned to one of six classified plaque groups for each of the four imaging time points.
  • the G * data can be expressed as G * ⁇ s G * , where G * is the average viscoelastic modulus computed for each plaque group at each imaging time point and SQ* is the standard deviation.
  • G * is the average viscoelastic modulus computed for each plaque group at each imaging time point
  • SQ* is the standard deviation.
  • Multiple factors can influence the viscoelastic modulus, G * .
  • the influence of following factors on G * can be evaluated: number of weeks on high fat diet, plaque type, animal within each plaque group, and blood cholesterol at each time point.
  • the differences between G * measurements influenced by these factors can be evaluated using three-way analysis of co-variance tests.
  • the three factors included in the analysis can be: imaging time point, plaque type, and animal within each plaque group.
  • the covariate in these tests can be the measured blood cholesterol level at each imaging time point.
  • Statistical significance to elucidate differences in G * measurements for the tests can be defined by a p- value ⁇ 0.05.
  • Fibrous cap thickness in the NCFA group can be determined from digitized Trichrome-stained histology sections. The relationships between G * and fibrous cap thickness in the NCFA set can be investigated using linear regression.

Abstract

Exemplary embodiments of apparatus and method for determining at least one material property of an anatomical structure can be provided. According to one exemplary embodiment, it is possible to apply at least one first coherent radiation to at least one portion of the anatomical structure, and receive at least one second coherent radiation from such portion(s). The first and second coherent radiations can be associated with one another. In addition, it is possible to determine the material property based on the second coherent radiation(s). Such determination can be performed without (i) any portion of an apparatus performing the procedure causing an induction of at least one mechanical deformation on or in the anatomical structure, and/or (ii) any mechanical deformation on or in the anatomical structure.

Description

NON-CONTACT OPTICAL SYSTEM, COMPUTER-ACCESSIBLE MEDIUM AND
METHOD FOR MEASURING AT LEAST ONE MECHANICAL PROPERTY OF
TISSUE USING COHERENT SPECKLE TECHNIQUE(S)
CROSS-REFERENCE TO RELATED APPLICATION(S) [0001] This application is based upon and claims the benefit of priority from U.S.
Patent Application Serial No. 61/159,474, filed on March 12, 2009, the entire disclosure of which is incorporated herein by reference.
FIELD OF THE DISCLOSURE
[0002] Exemplary embodiments of the present disclosure relates generally to measuring properties associated with tissues, and more particularly to non-contact optical system, computer-accessible medium and method for measuring at least one mechanical or material property of tissue using laser speckle.
BACKGROUND INFORMATION
[0003] In many pathological disease processes, the material properties of tissue are altered from a normal state. The development of techniques to measure the mechanical or material properties of tissue can potentially facilitate disease diagnosis and guidance of therapy. The system and methods described in this embodiment can potentially be applied for diagnosis of a variety of disease processes. To describe the technique, in this embodiment it is possible to focus on the cardiovascular applications for the detection of unstable atherosclerotic plaque.
[0004] Atherosclerotic Plaque Rupture and the Role of Bioniechanical Factors:
Despite widespread efforts towards its detection and therapy, thrombus mediated ischemic cardiovascular disease still remains the leading cause of mortality in industrialized societies. The rupture of unstable coronary atherosclerotic plaque frequently can precede a majority of ischemic cardiovascular events. The mechanisms leading to plaque rupture can be multi- factorial involving a complex liaison between morphological, compositional, biochemical and biomechanical processes. Due to the cumulative effect of multiple factors, the mechanical stability of the plaque is compromised resulting in an elevated risk of rupture. It is believed that during atherosclerotic plaque progression, the intrinsic mechanical properties of the plaque are serially altered and the measurement of a metric to accurately evaluate intrinsic plaque mechanical properties provides a key determinant of plaque stability. This belief can be based on evidence that mechanical factors greatly influence plaque stability. Hemodynamic forces affect wall shear stresses influencing plaque progression, susceptibility to plaque rupture and coronary thrombosis.6 Finite element studies have suggested that rupture of the fibrous cap is greatly influenced by regions of high circumferential stress typically in the lateral cap shoulders. The morphology and mechanical properties of the atheroma can affect stress distributions, with plaque rupture frequently occurring in focal regions of high stress concentrations caused by large differences in intrinsic mechanical properties of the fibrous cap and lipid pool. The mechanical properties of the atheroma determine the extent of induced deformation or strain in response to an extrinsic load. Higher strains are measured in lipid rich regions of lower viscosity. Cyclic mechanical strain within the arterial wall affects macrophage gene expression and SMC proliferation. Histology studies have shown the localization of MMP-I in regions of high circumferential strain within plaques, suggesting that mechanical properties influence MMP release further weakening plaque structure contributing to a greater tendency towards plaque rupture.
[0005] Image-based methods to measure arterial mechanical properties: A variety of techniques such as intravascular ultrasound (IVUS), virtual histology (VH)-IVUS, magnetic resonance imaging (MRI), angioscopy, thermography, near infrared (NIR) and Raman spectroscopy have been investigated for evaluating coronary plaques in patients. High resolution optical techniques such as optical coherence tomography (OCT) and its next generation implementation, optical frequency domain imaging (OFDI) can provide the opportunity to evaluate plaque microstructure and identify TCFA's in patients. These technologies provide invaluable information on microstructural, compositional and inflammatory factors related to plaque instability and are complementary to approaches that measure mechanical factors. To address the specific need for evaluating mechanical factors, IVUS elastography and finite element analysis (FEA) techniques have been developed. IVUS elastography computes local strains in the arterial wall in response to intra-luminal pressure differentials using cross-correlation analysis and estimation of tissue velocity gradients. Elastography approaches have been applied to OCT to potentially provide higher spatial resolution of strain estimation relative to IVUS. FEA approaches can utilize computer- generated models based on OCT or IVUS cross-sections and estimates of tissue material properties for modeling intra-plaque stress/strain distributions. These techniques provide important information in that they enable the measurement of plaque response to a dynamic external loading environment, thus aiding the investigation of plaque instability. However, the measurement of plaque viscoelasticity using these approaches is intractable, requiring a priori guesstimates of viscoelastic properties, and knowledge of microstructure and loading conditions to solve the inverse problem.
[0006] Viscoelasticity and Brownian Motion: Tissue is viscoelastic in nature, exhibiting both solid and fluid like characteristics. The mechanical properties of viscoelastic materials can be evaluated by measuring a quantity, termed the "viscoelastic modulus", which determines the strain induced in the material in response to an extrinsic load. Traditionally, the viscoelastic modulus is measured using a mechanical rheometer, in which a material is loaded between two parallel plates, an oscillatory stress at frequency, ω , is applied and the a strain response is measured to evaluate viscoelasticity. The measured viscoelastic modulus, G * (ω) , is expressed as, G * (ω) = G'(ω) + iG"(ω) . The real part, G'(ω) , is the elastic modulus which defines the elastic solid like characteristics of the material and is the ratio of the elastic component of the oscillatory stress which is in phase with the strain. The imaginary part, G"(ω) , provides the viscous modulus and measures the out-of-phase response of the medium defining the material's fluid like characteristics. The ratio between the elastic to viscous moduli provides a measure of 'phase', where a lower phase represents a more elastically dominated and a higher phase represents a more viscously dominated material.
[0007] Studies in the field of polymer rheology have demonstrated non-contact approaches to measure the viscoelastic modulus by evaluating the passive movements (Brownian motion) of particles suspended in a viscoelastic medium. In one publication, it was demonstrated that the Brownian motion of suspended particles is intimately related to the structure and viscoelastic properties of the suspending medium, and particles exhibit larger range of motions when their local environment is less rigid. This indicated that the response of a viscoelastic material to the average Brownian motion of dispersed microscopic particles closely resembles the response of the material to an imposed oscillatory mechanical load at frequency, OJ . Consequently, other studies have indicated the use of light scattering techniques to evaluate the viscoelastic modulus of homogenous polymer materials by suspending exogenous particles and measuring the time scale and mean square displacement of microscopic trajectories. By applying these concepts, a further exemplary optical technique can be reviewed, e.g., termed Laser Speckle Imaging, which analyzes the intrinsic Brownian motion of endogenous microscopic light scattering particles that are inherently present within tissue to evaluate tissue viscoelasticity.
[0008] Laser Speckle Imaging (LSI): When an object is imaged using highly coherent light from a laser, a granular pattern of multiple bright and dark spots becomes apparent on the image, which bears no perceptible relationship to the macroscopic structure of the object. These random intensity patterns, termed as laser speckle, can occur in two situations: (i) when coherent light is reflected from a surface which is rough on the scale of an optical wavelength, and (ii) when coherent light propagates through and is scattered by a medium with random refractive index fluctuations such as in tissue. The interference of light returning from the random surface or medium causes laser speckle. Laser speckle formed from scattering within tissue is exquisitely sensitive to Brownian motion. The Brownian motion of endogenous light scattering particles in tissue causes scatterer locations and optical path lengths to dynamically change resulting in time dependent intensity modulations of laser speckle. The rate of laser speckle modulation can be highly dependent on the extent of motion of suspended scatterers, which is in turn influenced by viscoelasticity of the medium. Consequently, in an atheroma, due to the relatively low viscosity of lipid, endogenous scatterers within the compliant necrotic core exhibit more rapid Brownian motion compared to the stiffer fibrous regions of the plaque. Since scatterer motion governs the modulation of laser speckle, the measurement of temporal intensity variations of laser speckle patterns provides information about the viscoelastic properties of the plaque. Using these principles, the measurement of intensity modulations of time-varying laser speckle patterns can provide a highly sensitive technique for evaluating atherosclerotic plaques. Exemplary procedures using excised atherosclerotic plaques have been reviewed, indicating that the measurement of intrinsic Brownian motion of endogenous particles, related to viscoelasticity, can be used to distinguish plaque type, and evaluate collagen and lipid content.
SUMMARY OF EXEMPLARY EMBODIMENTS OF THE DISCLOSURE
[0009] For example, (a) exemplary embodiments of the LSI techniques and systems according to the present disclosure can be provided for plaque characterization and identification of high-risk plaque, (b) the exemplary LSI time constant can be related to collagen and lipid content, (c) exemplary embodiments of the LSI techniques and systems according to the present disclosure can measure an index of viscoelasticity that can be related to the viscoelastic modulus, G*, (d) fibrous cap thickness can be measured using LSI (e) exemplary embodiments of the LSI techniques and systems according to the present disclosure can identify high-risk plaques during physiological arterial deformation, and (f) the apoE knockout mouse can provide a useful model to evaluate plaque progression. It is likely that exemplary embodiments of LSI techniques and system can provide an exemplary platform for measuring composite metrics of plaque stability based on biomechanical, structural and compositional factors. Exemplary measurements of time constant can be performed by fitting a single exponential to a portion of the normalized speckle decorrelation curve.
[0010] For example, by evaluating contributions of different time constants using multiexponential analysis of speckle decorrelation, it is possible to increase the efficacy of LSI in investigating plaque heterogeneity. The use of spatio-temporal analysis of exemplary embodiments of the LSI techniques and systems according to the present disclosure in providing depth information has been shown. When combined with beam scanning, this exemplary feature of the exemplary embodiments of the LSI techniques and systems can facilitate the measurement of three-dimensional maps of plaque viscoelasticity and morphology. Studies have shown that the measurement of the mean square displacement of particle trajectories obtained from diffuse light scattering techniques can be used to calculate the viscoelastic modulus in homogenous polymer solutions. These exemplary principles can be applied to determine the intrinsic viscoelastic modulus of tissue components from laser speckle patterns. [0011] One of the objects of certain exemplary embodiments of the present disclosure is to provide quantitative indices based on plaque biomechanical properties using LSI to determine the risk of plaque rupture. While certain preliminary studies have successfully demonstrated the capability of LSI in diagnosing plaque type, in order to realize the exemplary objects of the present disclosure, the exemplary embodiment of the LSI techniques and systems can facilitate its use to accurately quantify plaque viscoelasticity. According to one exemplary embodiment of the present disclosure, it is possible to facilitate exemplary methods and systems for measuring the viscoelastic properties of arterial tissue from, e.g., laser speckle images and compare our results with standard mechanical testing measurements.
[0012] According to another exemplary embodiment of the present disclosure, it is possible to determine changes in plaque viscoelasticity using the exemplary embodiments of the LSI systems and method during different stages of arterial atherosclerotic plaque progression in an atherosclerotic mouse model. Some of the capabilities of LSI that facilitate the measurement of tissue mechanical properties are listed: ♦Exemplary LSI techniques and system can measure intrinsic Brownian motions of endogenous scatterers providing measurements that are intimately linked with the micro-mechanical behavior of the tissue. ♦Exemplary LSI techniques and systems can be implemented using a relatively inexpensive laser source and a high-speed CMOS or CCD camera, enabling the study of tissue viscoelastic behavior 'in situ' over a large frequency range over several kHz, defined by the frame rate of the detector. ♦Exemplary LSI measurements can be sensitive to small changes in the viscoelastic properties of the tissue because speckle decorrelation induced by phase shifts in highly scattering media requires very minute displacements of scatterers at length scales smaller than the optical wavelength. ♦Beam scanning enables the unique ability to measure 2D distributions of tissue viscoelastic behavior. ♦High-speed CMOS or CCD technology (-kHz acquisition) enables speckle decorrelation measurements over very short time scales (few ms) over which the influence of low frequency arterial deformations induced by cardiac (-1Hz) or respiratory (-0.2 Hz) motion is largely mitigated. ^Exemplary LSI techniques and systems can be utilized implementing small-diameter optical fiber bundles, thus elegantly lending itself for intracoronary applications.
[0013] It is also possible to apply the exemplary techniques described herein to other optical methods that utilize coherent sources including optical methods such as, e.g., OCT, OFDI, SD-OCT and FD-OCT. The techniques described herein can also be applied to other methods that utilize other coherent radiation sources such as acoustic radiation including ultrasound. Ultrasound speckle patterns can be similarly analyzed to evaluate the viscoelastic properties of tissues by measuring ultrasound speckle decorrelation over finite time durations.
[0014] Exemplary embodiments of the LSI techniques and systems according to the present disclosure can be accurate for the detection of thin-cap fibroatheromas, and for measuring necrotic core area, fibrous cap thickness and plaque morphology ex vivo.
[0015] Exemplary LSI techniques and systems according to the present disclosure can be accurate for the detection of thin-cap fibroatheromas, and for measuring necrotic core area, fibrous cap thickness and plaque morphology ex vivo.
[0016] According to one exemplary embodiment of the present disclosure, it is possible to use such knowledge to measure the viscoelastic modulus, provide technology to conduct intra-arterial LSI in vivo, and derive key biomechanical markers for early detection of high-risk plaques.
[0017] Indeed, exemplary embodiments of apparatus and method for determining at least one material property of an anatomical structure can be provided. According to one exemplary embodiment, (e.g., using at least one first arrangement) it is possible to apply at least one first coherent radiation to at least one portion of the anatomical structure, and receive at least one second coherent radiation from such portion(s). The first and second coherent radiations can be associated with one another. In addition, (e.g., using at least one second arrangement) it is possible to determine the material property based on the second coherent radiation(s). Such determination can be performed without (i) any portion of an apparatus performing the procedure causing an induction of at least one mechanical deformation on or in the anatomical structure, and/or (ii) any mechanical deformation on or in the anatomical structure.
[0018] According to one exemplary embodiment of the present disclosure, the first and/or second coherent radiation(s) can be an electro-magnetic radiation. It is possible to scan the anatomical structure at multiple locations, e.g., simultaneously and/or sequentially. It is also possible to detect a scan of the anatomical structure at the multiple locations simultaneously and/or sequentially.
[0019] In another exemplary embodiment of the present disclosure, the material property can be spatially-varying or depth-varying, as well as an elastic property or a viscous property of the anatomical structure. Further, the material property can be a macroscopic property, a microscopic property and/or a mesoscopic property of the anatomical structure. Such material property can also be a strain on the anatomical structure.
[0020] According to still another exemplary embodiment of the present disclosure, it is possible (e.g., using the second arrangement) to determine the material property as a function of frequencies of motion of scatterers within the anatomical structure. The motion of the scatterers within the anatomical structure can be a Brownian motion.
[0021] In a further exemplary embodiment of the present disclosure, the first coherent radiation can be a multiply-scattered light, a single-scattered light, and/or coherent speckle. It is also possible (e.g., using the first arrangement) to apply the first coherent radiation(s) to at least one portion in-vivo. The first and/or second coherent radiation(s) can be an acoustic radiation.
[0022] These and other objects, features and advantages of the exemplary embodiment of the present disclosure will become apparent upon reading the following detailed description of the exemplary embodiments of the present disclosure, when taken in conjunction with the appended claims.
BRIEF DESCRIPTION OFTHE DRAWINGS
[0023] Further objects, features and advantages of the present disclosure will become apparent from the following detailed description taken in conjunction with the accompanying figures showing illustrative embodiments of the present disclosure, in which:
[0024] Figure 1 is an exemplary illustration of speckle patterns acquired from a thin- cap fibroatheroma (TCFA) showing time-dependent fluctuation of laser speckle;
[0025] Figure 2(A) is an exemplary graph of Speckle decorrelation curves obtained for three exemplary aortic specimens: TCFA, thick-cap fibroatheroma (TKFA), and fibrous aortic plaques;
[0026] Figure 2(B) is an exemplary chart illustrating mean τ computed for different plaque groups under static conditions;
[0027] Figure 3 is an exemplary graph illustrating G* measured using a rheometer in response to a oscillatory load at frequencies less than IHz;
[0028] Figure 4(A) is an exemplary graph of a spatial heterogeneity in τ obtained by beam scanning over a necrotic core fibroatheroma; [0029] Figure 4(B) is an exemplary graph of the spatial heterogeneity in τ obtained by beam scanning over a calcific plaque;
[0030] Figure 4(C) is an exemplary graph of the spatial heterogeneity in τ obtained by beam scanning over a fibrous plaque;
[0031] Figure 4(D) is an exemplary map illustrating a distribution of speckle decorrelation time constants over a lesion compared with the accompanying gross pathology;
[0032] Figure 5(A) is a graph of T(P) is plotted vs. distance p from source;
[0033] Figure 5(B) is an exemplary schematic illustration of a photon propagation through a two-layer model;
[0034] Figure 6(A) is an exemplary block diagram of an exemplary embodiment of a method according to the present disclosure which can be used to measure and validate sample viscoelasticity using the exemplary LSI techniques;
[0035] Figure 6(A) is an exemplary block diagram of an exemplary embodiment of a system according to the present disclosure which can be used to measure and validate the sample viscoelasticity using the exemplary LSI techniques;
[0036] Figure 7(A) is an exemplary graph of frequency-dependent complex viscoelastic moduli measured from laser speckle patterns of fat, cartilage and skeletal muscle using the exemplary embodiments of the methods and systems according to the present disclosure;
[0037] Figure 7(B) is an exemplary graph of frequency-dependent complex viscoelastic moduli measured from laser speckle patterns of calcific, fibrous and lipid-rich atherosclerotic plaques using the exemplary embodiments of the methods and systems according to the present disclosure;
[0038] Figure 8(A) is an exemplary gross pathology photograph of a human aortic segment;
[0039] Figure 8(B) is an exemplary map of the distribution of complex viscoelastic moduli measured at high frequency (-250 Hz) by scanning a focused beam over the human aortic sample shown in Figure 8(A);
[0040] Figure 8(C) is an exemplary map of the distribution of complex viscoelastic moduli measured at frequencies -100 Hz by scanning a focused beam over the human aortic sample shown in Figure 8(A);
[0041] Figure 8(D) is an exemplary map of the distribution of complex viscoelastic moduli measured at lower frequencies ~10 Hz by scanning a focused beam over the human aortic sample shown in Figure 8(A); and
[0042] Figure 9 is an exemplary graph of the spatial variation of speckle decorrelation time constant over a mouse aorta with a fibrous plaque.
[0043] Throughout the figures, the same reference numerals and characters, unless otherwise stated, are used to denote like features, elements, components or portions of the illustrated embodiments. Moreover, while the subject disclosure will now be described in detail with reference to the figures, it is done so in connection with the illustrative embodiments. It is intended that changes and modifications can be made to the described exemplary embodiments without departing from the true scope and spirit of the subject disclosure as defined by the appended claims. DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS
Exemplary Design
[0044] Measuring viscoelasticity of atherosclerotic plaques: Characterization of Atherosclerotic Plaque using LSI: The exemplary capability of the exemplary embodiments of the LSI systems and methods according to the present disclosure for differentiating atherosclerotic plaque type, and assessing plaque morphology and composition is demonstrated has been described in, e.g., S. Nadkarni, et al., "Characterization of atherosclerotic plaques by laser speckle analysis", Circulation, 2005. In this publication, 118 aortic specimens were obtained from 14 human cadavers using LSI. Light (632 nm) from a Helium-Neon laser was focused on the luminal surface of the artery, and a CMOS camera captured laser speckle images at 240 frames/s, as shown in Figure 1. Time-varying laser speckle images were analyzed using cross-correlation techniques to determine the speckle decorrelation time constant, r, which is inversely dependent on the rate of change of the speckle image. The plaques were histologically classified into the following groups: thin-cap fibroatheroma (TCFA), thick-cap fibroatheroma (TKFA), pathological intimal thickening (PIT), non-necrotic fibroatheroma (FA), intimal hyperplasia (IH), fibrous plaque, and fibrocalcific plaque (FC).1 The average speckle decorrelation time constant, τ , was computed for each plaque group.
[0045] Figure 2(A) shows examples of the normalized speckle decorrelation curves computed for three aortic plaques. The TCFA demonstrated rapid speckle decorrelation (τ = 28ms) as compared to TKFA (τ = 265ms) and fibrous plaque (τ = 540ms) . The average exemplary speckle decorrelation time constant, τ , computed for different plaque groups under static conditions are plotted in Figure 2(B). The results of the analysis of variance (ANOVA) and Dunnetts t- tests demonstrated highly significant differences in τ between the plaque groups (p < 0.0001) . TCFA's exhibited a significantly lower time constant (τ ~ 47ms) as compared to other lesions due to rapid Brownian motion of endogenous particles within the compliant necrotic core (p < 0.001) . As a result, the exemplary LSI technique demonstrated high diagnostic sensitivity (100%) and specificity (92%) for identifying TCFA's. Fibrous and fibrocalcific lesions were also easily discriminated from lipid- containing lesions due to their significantly higher time constants.
[0046] Relationship between plaque composition and laser speckle decorrelation:
The time constant, τ , shows high correlation with plaque collagen content (e.g., R=O.73; p<0.0001) when measured using polarized light microscopy of Picrosirius Red (PSR) stained sections. Further, a high correlation between r and minimum cap thickness (R=O.87; p<0.001) and a strong negative correlation (R=-0.81; p<0.0001) between τ and necrotic core area can be obtained. These exemplary results demonstrate that the exemplary LSI measurements of τ can be related to plaque collagen and lipid content.
[0047] Preliminary studies to evaluate viscoelastic modulus, G: Exemplary preliminary studies have been conducted to evaluate the bulk viscoelastic modulus, G, and its relationship with LSI measurements of τ using in homogenous collagen substrates and arterial plaques and using modeling studies. (The term, bulk viscoelastic modulus, G, can be used to define the overall modulus of the sample which integrates over the sample volume).
[0048] Homogenous collasen substrate studies: In one example, the exemplary LSI technique was performed on type I collagen gels at varying concentrations (0.2%, 0.3%, 0.4%, 0.6% and 0.8% m/v), and on cartilage disks (type II collagen) obtained from swine knees and ears. In gels, speckle decorrelation time constant, τ , showed high correlation with collagen concentration (R=O.99, p<0.002). Mechanical testing can be performed on all gel and cartilage samples using a Bohlin C-VOR rheometer (Malvern Instruments Inc., MA) to measure G(ω), (0.5<ω<10Hz). Figure 3 shows a graph with exemplary mechanical measurements of viscoelastic moduli of collagen gels obtained using a rheometer. In Figure 3, τ shows a high correlation with mechanical testing (R=0.97, pO.OOOl), establishing a strong relationship between LSI and viscoelasticity. Atherosclerotic plaque studies: In another example, the exemplary LSI technique was conducted by averaging τ values over 4mm disks of arterial sites, histologically confirmed as calcific, fibrous and NCFA. Mechanical testing was performed using the Bohlin rheometer, and the modulus, G, was measured by averaging G(ω) over the linear range. The G values measured for plaque groups were distinct [2.27x105 Pa (calcific), 3.65x103 Pa (fibrous) and 2.23x103 Pa (NCFA)], and LSI measurements of τ correlated well with G (R=0.99, p<0.001). The above exemplary results indicate a close relationship between LSI measurements of τ and G(ω) measured by mechanical testing.
[0049] For all plaques, G was approximately equal to the elastic modulus, G' , suggesting that the plaques were largely elastic in the measurement regime with a small viscous modulus, G" . These values correspond with previously published reports.39 ANOVA tests showed statistically significant differences in G for the three plaque types (p<0.001).
[0050] Modeling Analysis: To evaluate the effect of depth dependent variations in plaque viscoelasticity on the bulk viscoelastic modulus, the atherosclerotic plaque can be modeled as a multilayered cylinder of thickness, L and viscoelastic modulus, G. For the purpose of this exemplary model, the assumption that G«G can be made', which can be supported by ex-vivo exemplary analysis above. As an initial matter, the case of a NCFA can be considered, consisting of a fibrous cap layer of thickness Ll with modulus Gl , overlying lipid pool layer of thickness L2 with modulus G2, loaded between the parallel plates of a rheometer. The twisting moment M applied by the rheometer can be determined by the distribution of shear stresses, T, integrated across the cylinder of cross-sectional area, A. The moment, M, is given by:
M = \rTdA = G^-I2 dz (Ci) f ? where z ~ y ^A js tne pOiar moment of inertia and φ is the angular displacement in the sample. Since the moment M=M1=M2 for each layer, by evaluating equation (Cl) for each layer of thickness Ll and L2, and for the entire cylinder, L we deduce the expression: c =
Figure imgf000017_0001
[0051] Equation (Cl) shows that the overall bulk viscoelastic modulus of the plaque is related to the thickness and viscoelastic modulus of each layer. This equation (C2) can be applied to evaluate the relationship between the bulk modulus G and fibrous cap thickness in a NCFA, using previously reported values of Gl = 496 kPa, and G2 = 222 kPa, for fibrous and lipid rich tissue and evaluated the influence of varying fibrous cap thickness (e.g., 0-500 μm) on G (as shown in Figure3). This exemplary model can be extended to include multiple layers of varying depth-dependent viscoelasticity by using the generalized equation:
± = Σ±- G n Gι (C3)
[0052] These analyses suggest that the fibrous cap thickness greatly influences the bulk viscoelasticity of the plaque (see Figure 3), indicating that the measurement of the bulk viscoelastic modulus can potentially provide a quantitative metric to evaluate plaque stability.
[0053] Measuring tissue heterogeneity using Exemplary LSI Systems and Techniques: In the exemplary analyses described above, bulk viscoelasticity can be evaluated over the entire speckle image by illuminating a single location. Thus, the Brownian motion was integrated over the illuminated volume and information about tissue heterogenity was lost. These exemplary analyses have provided significant evidence to show that measuring bulk viscoelasticity alone can provide an important metric related to plaque stability. However, evaluation of compositional and structural heterogeneities provides additional information about the risk of rupture. Exemplary analyses described below determine the feasibility of in evaluating both, (i) spatial, and (ii) depth-dependent heterogeneities in viscoelastic properties using laser speckle.
[0054] Laser speckle to evaluate spatial (or transverse) heterogeneity: Laser speckle images can be obtained by scanning the laser beam at small spatial increments and the spatial distribution of τ can be measured across the plaque. Figures 4(A)-4(D) illustrate the transverse spatial variation of τ as a function of beam location. As the beam was scanned across each lesion, τ varied significantly depending on tissue type: τ was low (20 - 50 ms) in the necrotic core regions 405 (see graph 400 - shown in Figure 4(A)) and higher in the calcific 415 (-2200 ms as shown in graph 410 in Figure 4(B)) and fibrous 425 (~800ms as shown graph 420 in Figure 4(C)) regions. Figure 4(D) illustrates a two-dimensional map 435 of the spatial distribution of τ , measured by scanning the beam at 300μm increments across a lipid-rich plaque: a well-demarcated region 430 of low τ relative to the surrounding aortic tissue is seen. These exemplary results show that beam scanning can be utilized to evaluate spatial variation in plaque viscoelasticity to potentially detect heterogeneities such as calcific nodules and localized necrotic cores. [0055] Laser speckle to evaluate depth heterogeneity: Due to the diffusive properties of light propagation in tissue, photons returning from deeper regions have a higher probability of remittance farther away from the illumination location. While beam scanning can provide information about spatial heterogeneities, depth-dependent heterogeneities can be measured by analyzing variation in τ as a function of radial distance, p, from the illumination location in each speckle image. An exemplary embodiment of the method and system according to the present disclosure can be provided to obtain depth-dependent measurements by combining spatio-temporal laser speckle analysis with diffusion theory and Monte Carlo models of light propagation. Such exemplary method and system can be used to measure fibrous cap thickness in necrotic-core fibroatheromas (NCFA's), which can also be applied to evaluate depth-dependent viscoelasticity.
[0056] For example, laser speckle patterns of 20 NCFA's were analyzed and spatio- temporal speckle fluctuations were measured by exponential fitting of the windowed normalized cross-correlation of sequential speckle patterns to obtain τ(p). By analyzing the spatial variation in τ(p) the distance, p', can be obtained at which τ(p) dropped to 65% of its maximum value. Figure 5(A) shows a graph of τ(p) plotted vs. distance p from source and Figure 5(B) shows an exemplary schematic illustration of a photon propagation through a two-layer model. For example, Figure 5(A) shows that τ(p) is plotted vs. distance p from source. At distances < p1 , e.g., most photons traverse the fibrous cap and τ(p) is high. At distances > p' , e.g., a majority of photons traverse the necrotic core and τ(p) is low. A Monte Carlo look up table can be created to relate radial distance, p, across the speckle pattern to the maximum photon penetration depth, zmax(p), through the plaque. To measure cap thickness, the depth zmax(p'), can be evaluated at p= p', that highly correlated with histological measurements (R=O.78, pO.0001). Paired t-tests showed no significant difference from histological measurements (p=0.4). These exemplary findings indicate the possibility of measuring spatial and depth-dependent viscoelasticity using LSI, potentially providing insight into structural and compositional heterogeneities. Validation of exemplary methods to measure the viscoelastic properties of arterial tissue from laser speckle images
Overview: measurement of viscoelastic properties using laser speckle [0057] An exemplary embodiment of the method, computer-accessible medium and system to measure viscoelastic properties of atherosclerotic plaques from laser speckle images can be based on previously-established optical methods. For example, using certain dynamic light scattering techniques, a quantity termed the mean square displacement (MSD),
(Δr2(tj)
\ ' , can be measured which provides an assessment of scatterer motion such as Brownian motion in the tissue. The MSD can be related to the material's frequency- dependent viscoelastic modulus, ' ω' . To probe the mechanical properties of highly scattering media such as colloids and polymer gels, Diffuse Wave Spectroscopy (DWS) techniques can be utilized. With the exemplary DWS techniques, a laser beam can be provided incident on the sample and light scattered multiple times is collected using a single optical fiber in transmission or backscattering geometry.
[0058] To measure the Brownian motion dynamics of the ensemble of particles within the medium, the time-varying intensity fluctuations over a single speckle spot can be measured by averaging over several cross-correlation functions that evolve in time to obtain the function, 02( U
Figure imgf000020_0001
^ can be used to measure the MSD and the resulting elastic, G'(ω) , and viscous, (ω) , moduli and the resulting complex modulus ' ω' . These exemplary methods have been demonstrated in the field of polymer rheology to measure the viscoelastic properties of homogenous materials such as semiflexible actin gels, polyacrylamide networks and other complex fluids. In standard DWS, since 92 \ τ) js measured over a single speckle spot, data acquisition time is several orders of magnitude larger than the typical time scale of fluctuations (e.g., acquisition time of several minutes) which can be impractical for materials that exhibit slower particle dynamics. Advances in DWS technology have described the use of CCD cameras to simultaneously acquire multiple speckles over the sample ("multispeckle" DWS). This exemplary technique enhances the statistical accuracy in determining the MSD by simultaneous ensemble averaging of multiple speckle spots, significantly reducing the data acquisition time to a few ms. Previous analyses in polymer rheology indicated that 021 '/ functions measured using 'multispeckle DWS' and standard DWS show high agreement with an error < about 2%.
[0059] With the results from the exemplary "multispeckle" DWS techniques to measure polymer viscoelasticity, it is possible to apply these exemplary techniques to evaluate the viscoelastic properties of human tissue, e.g., atherosclerotic plaques. The term
"LSI" as used herein can be similar to the "multispeckle" DWS described in polymer rheology applications, but certainly not limited thereto. For plaque measurements, the evaluation of two-dimensional speckle images (e.g., in the exemplary LSI techniques and systems) instead of a single speckle spot (e.g., in standard DWS) can be advantageous as it can provide more complete information about tissue viscoelastic properties, and facilitate depth-resolved measurements potentially enabling the evaluation of important parameters such as the thickness and viscoelasticity of the fibrous cap and necrotic core. The exemplary procedures of such methods to provide and validate the measurement of plaque viscoelasticity using the exemplary embodiments of the LSI techniques and systems according to the present disclosure is shown in the block diagram of Figure 6(A).
[0060] For example, as shown in Figure 6(A), time varying laser speckle images can be acquired at high frames (block 610). The, in block 920, such time-varying laser speckle images acquired at high frame rates can be analyzed using exemplary cross-correlation techniques to obtain the speckle decorrelation curve, 92 ") (block 620). The MSD of particle motions such as Brownian motion can be estimated or measured from the speckle decorrelation data (block 630). Parameters that characterize the medium scattering properties required to estimate the MSD can be evaluated from time-averaged laser speckle images (block 680) and by using diffusion theory and Monte Carlo simulations of light propagation through the sample (block 670). The viscoelastic or complex modulus, 'ω' and the elastic, 'ω' and viscous, ' ω' moduli can be derived (block 640) and compared with standard mechanical testing measurements (block 650).
Exemplary LSI System and Instrumentation
[0061] An exemplary embodiment of the LSI system according to the present invention can be provided to acquire laser speckle images, as shown in Figure 6(B). For example, light from an unpolarized Helium Neon light source 670 (e.g., 632 nm, 30 mW) can be coupled into an optical fiber arrangement 675, such as a single-mode fiber. The beam can be expanded by, e.g., 5: 1, reflected off a galvanometer-mounted mirror 680,and focused to, e.g., a 50μm diameter spot on the surface of a sample 685. The galvanometer-mounted mirror 680 can be computer-controlled by a computer 690 to facilitate scanning the illumination beam across the sample 685. It is also possible to illuminate the tissue surface of the sample 685 using a larger diameter extended beam or a collimated beam. At the collection end of the exemplary system, a collection arrangement 695, such as, e.g.,, a high-speed, digital CCD or CMOS camera (e.g., Mikrotron MC 1310) configured to acquire speckle patterns at high frame rates may be provided and images can be transferred to the computer 670 in real time. Time-varying cross polarized laser speckle images can be acquired from imaging sites on the tissue sample 685. Exemplary Laser Speckle Image Analysis: Measurement of mechanical properties such as viscoelastic moduli
[0062] Exemplary acquired time-varying laser speckle patterns can be analyzed using
cross-correlation techniques to determine the speckle cross-correlation function, 92(V The normalized 2D cross-correlation of the first speckle image with each image in the time- varying image series can be determined using the exemplary embodiments of the present disclosure. The maximum value of normalized cross-correlation can be determined and
plotted as a function of time over the acquisition duration to obtain the 92\ *) CUrve for each
tissue sample. To measure the viscoelastic properties of the sample, the 92( O curve can be evaluated to obtain the MSD and the resulting elastic, viscous and complex moduli. The ensemble speckle cross-correlation function, 02( f/ 5 can t>e expressed in terms of the MSD,
/ 2 \
\ ' , of scattering particles as follows,
g2(t) -l=[ ]dsP(s)exp{ -(s/3r)k2Ur2(t)) ) ]2 (Dl)
where P(s) is the distribution of photon trajectories traversing a path length, s, and k = 2ππ / λ , is the wave number of light in a medium where n is the refractive index and λ , the wavelength of light. The mean free path, / * , can characterize the scattering medium and is defined as the distance a photon travels before its direction is completely randomized. The exemplary embodiment of a method according to the present disclosure that can be used to estimate the parameters, P(s) and / * , preferable to calculate the MSD in equation (Dl) is described below.
[0063] For example, it is possible to utilize the exemplary mathematical methods that have been derived and established in previous DWS analyses in homogenous polymers to
measure ( ω) , in these exemplary methods, a modified algebraic form of the generalized Stokes-Einstein equation directly relates the MSD of probe particles to the frequency dependent viscoelastic modulus, ' ω' , of the material (equation . D2).
Figure imgf000024_0001
where G * (ω) is the frequency dependent complex viscoelastic modulus, a is the scatterer
size, r is the gamma function, and (Δr (1/ω)) is the magnitude of the MSD at t = 1 /ω . The value of α(ω) can be given by:
Figure imgf000024_0002
[0064] The particle size, a , is the characteristic length scale probed and can be given by,
Figure imgf000024_0003
where z0 is the penetration depth. From previous studies it is estimated that Z0 ~ 0.6p in arterial tissue, where p is the radial distance on the 2D speckle image measured from the central illumination location.
[0065] Average particle sizes of different tissue types can also be estimated using an iterative process by 'ω' using a mechanical rheometer, and retrospectively deducing particle size, a, values using equation (D2). This a priori estimate of particle size can then be applied to measure viscoelastic properties from laser speckle patterns for prospective measurements of tissue samples. [0066] The elastic, 'ω' , and viscous, (ω) , moduli can be determined using the following relations:
G'(ω) = \G * (ω)\ cos(πa(ω) / 2) G" (ω) = \G * (ω)\ sin(πa(ω) 12)
[0067] These exemplary relations can provide a direct physical representation of how the elastic modulus and viscous modulus of the material depend on the MSD. In a purely viscous medium, a = 1 resulting in a dominant loss modulus, and in a purely elastic medium a ~ 0 and the elastic modulus dominates.
Exemplary Estimation of parameters: P(s) and / * [0068] The exemplary evaluation of the MSD techniques of probe particles from the gft) function as expressed in equation (Dl) can utilize the measurement of the distribution of photon trajectories, P(s) , traversing a path length s, and the mean free path, / * . The parameters, P(s) and / * which characterize the optical properties of scattering medium can be derived from time-averaged speckle images using previously described methods. It is possible to determine optical properties of human tissue by combining a diffusion theory model of spatially-resolved diffuse reflectance58 and a Monte-Carlo model of light transport in tissue. According to one exemplary embodiment of the present disclosure, it is possible to utilize these exemplary methods to obtain the parameters, P(s) and / * . The sample can be described by its optical parameters: the absorption coefficient, μa , the scattering coefficient, μs, and the anisotropy coefficient, g , as well as the refractive indices of air and tissue (n = 1.4) First, it is possible to derive the optical properties of the sample by measuring the radially dependent remittance from the sample. Apriori estimates of tissue optical properties can also be used. [0069] Time-varying speckle images of the fibrous plaque can be obtained using the imaging the exemplary embodiment of the system and method according to the present disclosure as described herein. Given the quantum efficiency and gain of the CCD camera, the total number of diffuse photons remitted from the plaque and detected by the CCD sensor can be measured by time-averaging speckle images acquired over a time duration of a few seconds or longer. The radially-resolved photon probability, 'P) , for the fibrous plaque can be generated by summing the number of photons detected over different annuli of radii P , and then normalizing this value by the total number of photons detected over the area of the detector. Further, the theoretical radial photon probabilities determined from a single- scatterer diffusion model for the case of a semi-infinite homogeneous tissue58 can be fitted to the measured radial photon probabilities, "'P) , using a least-square optimization procedure, to extract the optical properties, ^a , ^s and ^ , of the sample. The mean free path, / * , can be then evaluated for the scattering medium, which is given by ~ ' Va '' ' Vs ) . When the optical properties are established, they can be used as inputs to a Monte Carlo model which assumes a semi-infinite homogenous layer.49 Photon initial conditions can include input beams perpendicular to the semi-infinite layer. Multiple runs can be performed with the same set of optical properties and photon packet trajectories can be launched. Remitted photons can be collected over a radial distance of a few mm. From the output of the Monte Carlo simulations, the maximum path length, s, traversed by each photon can be recorded and the path length distribution, ' s) , of photons can be measured. The parameters, 's' and / * , can be input into equation Dl to determine the MSD of probe Brownian motion in the sample. Exemplary Methods
[0070] Exemplary LSI system optics: Optics for light delivery and speckle image transmission can be designed and optimized using, e.g., ZEMAX (ZEMAX Development Corporation). A variety of different lenses can be simulated and optimization can be performed to minimize aberrations through different optical window designs and to increase field of view. Following the optimized design and selection of configuration and components, optical elements can be obtained. The laser, illumination and collection optics, optical fibers, CCD camera, galvanometer-controlled mirror, linear translation device, and computer can be integrated in a portable cart. Software can control the motors, reading and storing motor encoder positions, laser speckle analysis, and displaying data in a various formats for ease of interpretation.
Exemplary Collagen phantom preparation for LSI
[0071] Since Type I collagen can be a predominant constituent of the extracellular matrix in atherosclerotic plaques, test phantoms can be made using commercially available collagen to evaluate the performance of LSI in measuring sample viscoelasticity. Collagen gels (Type I) can be constructed from rat tail tendon collagen dissolved in 0.02N acetic acid (8mg/ml) (BD Biosciences, catalog no. 354249). Latex microspheres with a diameter of about 0.3 μm (10% in water) can be used as light scattering probes. To evaluate the influence of collagen concentration on the measured viscoelastic modulus, collagen gels can be constructed with at each collagen concentration of 0.7%, 0.5%, 0.3%, 0.2%, and 0.1% (mass/volume). Since collagen can dissolve only in an acidic medium, and forms gels only in a neutral medium of pH from about 7 to 8, a high pH buffer can be used to neutralize the acetic acid in the collagen solution. A high pH buffer can be used. Exemplary Coronary atherosclerotic plaque specimens
[0072] Cadaveric coronary arterial segments can be excised during autopsy, and slit longitudinally open to expose the luminal surface. The coronary segments can be immersed in phosphate buffered saline and warmed to 37°C before imaging.
Exemplary Laser Speckle Imaging of Samples
[0073] Time-varying laser speckle images of the coronary arterial specimens and collagen gel phantoms can be obtained over a measurement duration of about I s, according to one exemplary embodiment of the present disclosure. For example, each sample can be stabilized on a cork-board, clamped onto an L-brackets mounted on a linear motorized stages. The L-brackets can be immersed in a PBS bath maintained at about 37°C such that the luminal surface of the artery (or surface of the collagen gel) is exposed just above the level of PBS. In the exemplary arterial specimens, time-varying laser speckle images can be obtained at randomly selected discrete lesion sites along the segment. Each imaging site can be marked with two India ink spots marking the diameter of the speckle pattern over the lesion, to facilitate accurate registration with mechanical testing measurements and histopathology. Circular sections can be cut across the artery at each marked imaging site using a 1mm circular punch biopsy too and stored in, e.g., PBS. In the collagen gel phantoms laser speckle images can be obtained three randomly selected sites for each gel to evaluate heterogeneity. In all samples, the frequency-dependent viscoelastic modulus, G * (ω) , can be computed at each spatial location from the time-varying laser speckle images using techniques described above. Following LSI, the samples can be prepared for standard mechanical testing procedures.
Exemplary Mechanical Testing
[0074] Mechanical testing to measure the viscoelastic properties of the coronary arterial specimens and collagen gel phantoms can be performed using a Bohlin C-VOR computer-controlled mechanical rheometer (e.g., Malvern Instruments, Southborough, MA). An exemplary embodiment of the system according to the present disclosure can include two parallel plates that can hold the sample affixed to the bottom plate to prevent slipping. A shear stress can be delivered to the sample by the motor via an oscillatory torque applied to the top plate. The resultant strain in the sample can be measured by an angular position sensor incorporated in the exemplary system and automated Bohlin system software can calculate G * (ω) , G'(ω) and G"(ω) . The mechanical testing can be conducted at, e.g., about 370C. In the first stage of mechanical testing, a gradually increasing stress can be applied and the strain response can be recorded.
[0075] The resultant viscoelastic modulus, G * , can be plotted as a function of measured strain to determine the range of linear strain response over which G * is independent of strain to provide an estimate of the mechanical strength of each sample. The threshold strain, γmaχ , can be determined above which the sample's intermolecular forces are overcome by the stress and the sample viscoelastic modulus falls. In the second stage of mechanical testing, an oscillatory strain can be induced in the sample swept through a frequency range, 1 < ω ≤ 100 Hz . The maximum strain can be maintained at γmaχ . The lower limit of the frequency range can be determined by the imaging time (1 s) over which the exemplary LSI techniques is performed and the upper limit, ω = 100Hz , can be limited by, e.g., the maximum frequency limit of the Bohlin rheometer system. The frequency dependent viscoelastic, G * (ω) , elastic, G'(ω) and viscous, G"(ω) , modulii can be recorded for each sample.
[0076] Exemplary LSI measurements of viscoelastic moduli performed in the coronary specimens and collagen gel phantoms can be compared with mechanical testing and Histological measurements of plaque collagen content. Exemplary results are shown below: [0077] Single location measurements: Using the exemplary methods described herein, in one example, the techniques above were applied to measure viscoelastic moduli from laser speckle patterns of animal tissue specimens such as cartilage, muscle and fat. In this example, the overall "macro" viscoelastic modulus of bulk tissue within the illuminated volume can be measured from the MSD data determined over the entire speckle pattern obtained by focusing the beam to a 50 μm spot. The exemplary results are shown in Figure 7A which illustrates the bulk viscoelastic moduli measurements plotted as a function of frequency measured from laser speckle patterns of cartilage 700, skeletal muscle 705, and adipose fat at temperatures of 4°C 710 and 400C 715. The exemplary results indicate that cartilage 700 has highest modulus values compared to skeletal muscle 705 and adipose fat 710, 715. Additionally, temperature influences sample viscoelasticity evidenced here by a lower modulus measured for adipose fat at 400C 715 compared to that at 40C 710.
[0078] In another example, the exemplary techniques described herein above were applied to human atherosclerotic plaques. Figure 7B shows the exemplary LSI measurements of plaque viscoelasticity obtained from human atherosclerotic plaques. The results demonstrate that higher moduli measurements were measured for the calcific plaques 720 and fibrous plaques 725 compared to the lipid-rich plaque 730. At higher frequency regions of the
G(ω> plot, the viscoelastic modulus of fibrous plaque 725 was significantly higher than lipid rich tissue 730 compared to the lower frequency regions.
[0079] Viscoelasticity mapping: While laser speckle patterns obtained by beam focusing (as described above) can provide information about tissue viscoelasticity over the illuminated volume, scanning a collimated or focused beam over a sample can facilitate the evaluation of spatial heterogeneities in viscoelastic moduli. For example, Figures 8(A)-8(D) show an example of two-dimensional maps of the frequency dependent modulus, G( ω) , measured by scanning a 5mm collimated beam over a 5cm region of a human cadaveric artery. In this case, G(ω) values were computed from MSD data measured within overlapping windowed regions of 100 x 100 μm over the artery. Two-dimensional maps of G(ω) can be obtained by performing an interpolation over the region of interest. In Figures 8(B)-8(D), G(ω) maps computed at different frequencies are plotted, respectively, and compared with a gross pathology photograph (Figure 8(A)) of the artery, in which calcific regions 800, fibrous regions 805 and lipid-rich regions 810 are demarcated. The India ink spot 815 is also visible in the maps, and can used for accurate registration of the G(ω) maps with the gross pathology image. As seen in G(ω) plots, at higher frequencies the calcific tissue types 820, fibrous tissue types 825 and lipid-rich tissue types 830 are distinguished by significant differences in their viscoelastic moduli. At lower frequencies (shown in Figures 8(C) and (D)), G(ω) differences between fibrous and lipid-rich tissue types are not highly significant. These exemplary results demonstrate the ability to measure heterogenous moduli by beam scanning simultaneously over a large range of frequencies using a non-contact optical approach. Another exemplary method to accomplish two-dimensional mapping of tissue viscoelastic moduli can be performed by illumination using an extended beam and the resulting speckle patterns can be analyzed by employing windowed over a varying range of scales (microscopic, mesoscopic and macroscopic), of g2 (t) over a single speckle spot or multiple speckle spots over the illuminated tissue. Thus, it is possible to evaluate tissue viscoelastic moduli over a varying range of scales (microscopic, mesoscopic and macroscopic). Exemplary method to monitor changes in tissue mechanical properties during disease progression: changes in arterial viscoelastic properties using LSI during plaque progression in a mouse model of atherosclerosis
[0080] For example, mechanical strength of the plaque, determined by the viscoelastic modulus, G * , can be modified and compromised during plaque progression. By monitoring G * during different stages of atherogenesis, quantitative biomechanical markers can be used to evaluate the risk of rupture.
Exemplary Monitoring changes in arterial viscoelasticity during plaque progression [0081] It is possible to use the exemplary methods according to the present disclosure as described herein above to monitor arterial viscoelastic moduli during different stages of atherosclerosis progression in a murine model. For example, it is possible to evaluate the influence of multiple factors on the arterial viscoelasticity specifically: stage of atherogenesis (imaging time point), plaque type and blood cholesterol. Mice on a high fat diet can be investigated at four imaging time points. LSI of murine aortic, brachiocephalic, carotid arteries and the iliac bifurcation can be conducted. Time-varying laser speckle images can be analyzed to measure arterial viscoelastic moduli. Arterial viscoelasticity can be serially monitored at each imaging time point and compared with Histopathological findings at sacrifice.
Further Exemplary Methods
[0082] Below, exemplary embodiments of the methods and systems according to the present disclosure to evaluate and monitor arterial viscoelastic properties during atherosclerosis progression in atherosclerotic mice can be utilized.
Exemplary Mouse Model of Atherosclerosis [0083] Exemplary use of atherosclerotic mouse model: An atherosclerotic mouse model using Apolipoprotein E knockout (ApoE -/-) mice (background strain - C57BL/6) can be used to review this exemplary embodiment. This exemplary model can be based on previous analyses which indicated that advanced necrotic core plaques resulting in plaque rupture occurred in apoE-knockout mice after 8 weeks of fat feeding. The exemplary LSI analyses can be implemented to (i) evaluate the use of apo E-/- mice to evaluate plaque progression, and (ii) to test the feasibility of measuring viscoelasticity of mouse arteries using laser speckle techniques.
[0084] The apolipoprotein E knockout (ApoE -/-) murine model has been shown to be a reliable and reproducible model for atherosclerosis, and its lesion characteristics are similar to those associated with plaque instability in humans. The feasibility of measuring arterial viscoelasticity of aortic plaques can be assessed in apo E-/- mouse arteries. In one study, segments of the abdominal aorta were obtained from a fat fed apo E-/- mouse at 14 weeks. For example, an exemplary LSI procedure was conducted by scanning a focused (20μm) beam (632nm) and measuring τ , at 300 μm increments along the length of the aorta. Figure 9 shows the spatial distribution of τ 900 co-registered with the corresponding gross pathology photograph of the mouse aorta 905, and measured by beam scanning which shows evidence of fibrous plaque with varying mechanical properties. The τ value varied significantly and was higher in region corresponding the location of the plaque (τ =462ms) suggesting the presence of a fibrous plaque. Lower τ values adjacent to the fibrous plaque may be attributed to hyperlipidemia in the apo E-/- mouse. This exemplary data indicates that by beam focusing in conjunction with scanning, the exemplary LSI technique and system according to the present disclosure can detect plaques in mouse arteries
[0085] Multiple mice can be used; for example, 48 C57BL/6 ApoE -/- and 12 regular
C57BL/6 mice (control) can be studied. Starting at about 6 weeks of age, the 48 ApoE -/- mice can be placed on a high fat diet (e.g., 0.2% cholesterol, 21% fat, Harlan Tekland #88137) and 12 control mice continued on a regular chow diet (0% cholesterol, 5.7% fat, Harlan Tekland #2018). For example, the first imaging time point can be at 6 weeks after initiation of the high fat diet. At each time point, 12 ApoE -/- and 3 control mice can be randomly selected and sacrificed. The mouse vasculature can be prepared for imaging and LSI measurements along with corresponding Histopathology can be performed on each animal (as described below). Subsequently, the second, third and forth imaging time point can be, e.g., at 12 weeks, 18 weeks and 24 weeks after initiation of the high fat diet. LSI and Histopathological measurements can proceed in the manner described for the first imaging time point. At each imaging time point, blood samples can be drawn from both ApoE -/- and control mice, and total cholesterol can be determined enzymatically. The exemplary sites of lesion prediliction in the apoE -/- mouse aorta are shown in Figure 9.
Exemplary Laser Speckle Imaging of mouse vasculature
[0086] Development of atherosclerotic lesions in the vasculature of mice can occur at reproducible sites which are predominantly dictated by hemodynamic forces experienced by the endothelium. Thus, it is possible to select arterial segments in the mouse vasculature to conduct LSI to coincide with arteries exhibiting plaque predilection. The aorta (including the ascending, thoracic and abdominal aorta), brachiocephalic trunk, right and left common carotids and the iliac bifurcation can be imaged using for LSI. Similarly, the brachiocephalic trunk, and the left and right common carotid arteries can be imaged in 1 mm increments advancing from the aortic arch towards the carotid bifurcation. Time-varying laser speckle images can be obtained at high frame rates at each imaging site over a measurement time duration determined using the exemplary embodiments described herein above.
Exemplary Histological Processing and Analysis
[0087] Following the exemplary imaging, the arterial segments can be fixed in about 10% formalin, embedded and sectioned using standard Histology techniques. Cross-sectional sections (thickness = 4 μm) can be cut over the length of each aortic, brachiocephalic and common carotid arteries. The sections can be stained with H & E and Trichrome stains, and interpreted by a pathologist blinded to the LSI data. Atherosclerotic lesions and the natural history of their progression in the apoE-knockout mouse bear a resemblance to atherogenesis in humans. Fatty streaks are present in early stages and as lesions progress multilayered appearances occur showing presence of smooth muscle cells. Advanced lesions indicated fibrous cap appearance, necrotic core, cholesterol clefts and calcifications. Spontaneous plaque rupture has been shown in fat fed mice with the fibrous cap significantly thinner in ruptured lesions than intact lesions. Due to the similarities with human atherosclerosis, it is possible to characterize atherosclerotic lesions in apoE-knockout mice based on the classification scheme proposed by Virmani et al. Atherosclerotic lesions can be classified into the following six groups: intimal xanthoma (or fatty streak), intimal thickening (IT), necrotic core fibroatheroma (NCFA), ruptured plaque, fibrous plaque and calcific plaque.
Exemplary Statistical Analysis [0088] Exemplary time-varying laser speckle images obtained from the mouse vasculature can be evaluated using the exemplary techniques described herein above. The frequency dependent viscoelastic modulus, G * (ω) , can be measured from the mean square displacement of plaque particles which will determined from the speckle cross correlation curve, gft) - The value of the viscoelastic modulus, G * at the optimal frequency, ω , (as described herein above) can be recorded from the G * (ω) data. Bas ed on histological diagnoses, the G * value associated with each lesion can be assigned to one of six classified plaque groups for each of the four imaging time points. For each plaque type, the G * data can be expressed as G * ± sG* , where G * is the average viscoelastic modulus computed for each plaque group at each imaging time point and SQ* is the standard deviation. [0089] Multiple factors can influence the viscoelastic modulus, G * . For example, the influence of following factors on G * can be evaluated: number of weeks on high fat diet, plaque type, animal within each plaque group, and blood cholesterol at each time point. The differences between G * measurements influenced by these factors can be evaluated using three-way analysis of co-variance tests. The three factors included in the analysis can be: imaging time point, plaque type, and animal within each plaque group. To determine whether blood cholesterol is a determining factor that influences the value of G * , the covariate in these tests can be the measured blood cholesterol level at each imaging time point. Statistical significance to elucidate differences in G * measurements for the tests can be defined by a p- value < 0.05. Fibrous cap thickness in the NCFA group can be determined from digitized Trichrome-stained histology sections. The relationships between G * and fibrous cap thickness in the NCFA set can be investigated using linear regression.
[0090] The foregoing merely illustrates the principles of the invention. Various modifications and alterations to the described embodiments will be apparent to those skilled in the art in view of the teachings herein. Indeed, the arrangements, systems and methods according to the exemplary embodiments of the present disclosure can be used with and/or implement any OCT system, OFDI system, SD-OCT system or other imaging systems, and for example with those described in International Patent Application PCT/US2004/029148, filed September 8, 2004 which published as International Patent Publication No. WO 2005/047813 on May 26, 2005, U.S. Patent Application No. 1 1/266,779, filed November 2, 2005 which published as U.S. Patent Publication No. 2006/0093276 on May 4, 2006, and U.S. Patent Application No. 10/501,276, filed July 9, 2004 which published as U.S. Patent Publication No. 2005/0018201 on January 27, 2005, and U.S. Patent Publication No. 2002/0122246, published on May 9, 2002, the disclosures of which are incorporated by reference herein in their entireties. It will thus be appreciated that those skilled in the art will be able to devise numerous systems, arrangements and methods which, although not explicitly shown or described herein, embody the principles of the invention and are thus within the spirit and scope of the present disclosure. In addition, to the extent that the prior art knowledge has not been explicitly incorporated by reference herein above, it is explicitly being incorporated herein in its entirety. All publications referenced herein above are incorporated herein by reference in their entireties.

Claims

WHAT IS CLAIMED IS:
1. An apparatus for determining at least one material property of an anatomical structure, comprising: at least one first arrangement which is configured to apply at least one first coherent radiation to at least one portion of the anatomical structure; and at least one second arrangement which is configured to receive at least one second coherent radiation from the at least one portion, the first and second coherent radiations being associated with one another, wherein the at least one second arrangement is further configured to determine the at least one material property based on the at least one second coherent radiation, and wherein the determination by the at least one second arrangement is performed without at least one of: i. any portion of the apparatus causing an induction of at least one mechanical deformation on or in the anatomical structure, or ii. any mechanical deformation on or in the anatomical structure.
2. The apparatus according to claim 1, wherein at least one of the at least one first coherent radiation or the at least one second coherent radiation is an electro-magnetic radiation.
3. The apparatus according to claim 1, wherein the at least one first arrangement is configured to scan the anatomical structure at multiple locations.
4. The apparatus according to claim 3, wherein the at least one first arrangement scans the anatomical structure at the multiple locations simultaneously.
5. The apparatus according to claim 3, wherein the at least one first arrangement scans the anatomical structure at the multiple locations sequentially.
6. The apparatus according to claim 3, wherein the at least one second arrangement detects a scan of the anatomical structure at the multiple locations simultaneously.
7. The apparatus according to claim 3, wherein the at least one second arrangement detects a scan of the anatomical structure at the multiple locations sequentially.
8. The apparatus according to claim 1, wherein the at least one material property determined by at least one second arrangement is spatially-varying or depth-varying.
9. The apparatus according to claim 1, wherein the at least one material property determined by at least one second arrangement is an elastic property or a viscous property of the anatomical structure.
10. The apparatus according to claim 1, wherein the at least one material property is a macroscopic property of the anatomical structure.
11. The apparatus according to claim 1, wherein the at least one material property is a microscopic property of the anatomical structure.
12. The apparatus according to claim 1, wherein the at least one material property is a mesoscopic property of the anatomical structure.
13. The apparatus according to claim 1, wherein the at least one material property determined by at least one second arrangement is a strain on the anatomical structure.
13. The apparatus according to claim 1, wherein the at least one second arrangement is configured to determine the at least one material property as a function of frequencies of motion of scatterers within the anatomical structure.
14. The apparatus according to claim 13, wherein the motion of the scatterers within the anatomical structure is a Brownian motion.
15. The apparatus according to claim 1, wherein the at least one first coherent radiation is a multiply-scattered light.
16. The apparatus according to claim 1, wherein the at least one first coherent radiation is a single-scattered light.
17. The apparatus according to claim 1, wherein the at least one first coherent radiation is coherent speckle
18. The apparatus according to claim 1, wherein the at least one first arrangement applies the at least one first coherent radiation to at least one portion in-vivo.
19. The apparatus according to claim 1, wherein at least one of the at least one first coherent radiation or the at least one second coherent radiation is an acoustic radiation.
20. A method for determining at least one material property of an anatomical structure, comprising: applying at least one first coherent radiation to at least one portion of the anatomical structure; receiving at least one second coherent radiation from the at least one portion, the first and second coherent radiations being associated with one another; and determining the at least one material property based on the at least one second coherent radiation, wherein the determination is performed without at least one of: i. any portion of an apparatus performing the method causing an induction of at least one mechanical deformation on or in the anatomical structure, or ii. any mechanical deformation on or in the anatomical structure.
PCT/US2010/027193 2009-03-12 2010-03-12 Non-contact optical system, computer-accessible medium and method for measuring at least one mechanical property of tissue using coherent speckle techniques(s) WO2010105197A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US13/256,175 US9351642B2 (en) 2009-03-12 2010-03-12 Non-contact optical system, computer-accessible medium and method for measurement at least one mechanical property of tissue using coherent speckle technique(s)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15947409P 2009-03-12 2009-03-12
US61/159,474 2009-03-12

Publications (2)

Publication Number Publication Date
WO2010105197A2 true WO2010105197A2 (en) 2010-09-16
WO2010105197A3 WO2010105197A3 (en) 2011-01-13

Family

ID=42729143

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/027193 WO2010105197A2 (en) 2009-03-12 2010-03-12 Non-contact optical system, computer-accessible medium and method for measuring at least one mechanical property of tissue using coherent speckle techniques(s)

Country Status (2)

Country Link
US (1) US9351642B2 (en)
WO (1) WO2010105197A2 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012101644A3 (en) * 2011-01-28 2012-11-01 Bar Ilan University Method and system for non-invasively monitoring biological or biochemical parameters of individual
US20150305681A1 (en) * 2012-12-19 2015-10-29 The General Hospital Corporation Optical Blood-Coagulation Sensor
EP2676123A4 (en) * 2011-02-18 2016-01-20 Gen Hospital Corp Laser speckle microrheometer for measuring mechanical properties of biological tissue
US9636041B2 (en) 2011-01-28 2017-05-02 Bar Ilan University Method and system for non-invasively monitoring biological or biochemical parameters of individual
CN108542499A (en) * 2012-05-14 2018-09-18 直观外科手术操作公司 Deformation-compensated system and method for using shape to sense
US10398314B2 (en) 2012-08-01 2019-09-03 Bar Ilan University Method and system for non-invasively monitoring biological or biochemical parameters of individual
CN111981997A (en) * 2020-07-21 2020-11-24 广东工业大学 PS-OCT strain estimation method based on large deformation
CN112740015A (en) * 2019-02-28 2021-04-30 地方独立行政法人神奈川县立产业技术综合研究所 Fluid sample internal structure observation device and internal structure analysis system, fluid sample internal structure observation method and internal structure analysis method, and ceramic manufacturing method

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11229472B2 (en) 2001-06-12 2022-01-25 Cilag Gmbh International Modular battery powered handheld surgical instrument with multiple magnetic position sensors
US8182501B2 (en) 2004-02-27 2012-05-22 Ethicon Endo-Surgery, Inc. Ultrasonic surgical shears and method for sealing a blood vessel using same
PL1802245T3 (en) 2004-10-08 2017-01-31 Ethicon Endosurgery Llc Ultrasonic surgical instrument
US20070191713A1 (en) 2005-10-14 2007-08-16 Eichmann Stephen E Ultrasonic device for cutting and coagulating
US7621930B2 (en) 2006-01-20 2009-11-24 Ethicon Endo-Surgery, Inc. Ultrasound medical instrument having a medical ultrasonic blade
US8142461B2 (en) 2007-03-22 2012-03-27 Ethicon Endo-Surgery, Inc. Surgical instruments
US8911460B2 (en) 2007-03-22 2014-12-16 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments
US8057498B2 (en) 2007-11-30 2011-11-15 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instrument blades
US8808319B2 (en) 2007-07-27 2014-08-19 Ethicon Endo-Surgery, Inc. Surgical instruments
US8523889B2 (en) 2007-07-27 2013-09-03 Ethicon Endo-Surgery, Inc. Ultrasonic end effectors with increased active length
US8430898B2 (en) 2007-07-31 2013-04-30 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments
US9044261B2 (en) 2007-07-31 2015-06-02 Ethicon Endo-Surgery, Inc. Temperature controlled ultrasonic surgical instruments
US8512365B2 (en) 2007-07-31 2013-08-20 Ethicon Endo-Surgery, Inc. Surgical instruments
JP2010540186A (en) 2007-10-05 2010-12-24 エシコン・エンド−サージェリィ・インコーポレイテッド Ergonomic surgical instrument
US10010339B2 (en) 2007-11-30 2018-07-03 Ethicon Llc Ultrasonic surgical blades
US9089360B2 (en) 2008-08-06 2015-07-28 Ethicon Endo-Surgery, Inc. Devices and techniques for cutting and coagulating tissue
US9700339B2 (en) 2009-05-20 2017-07-11 Ethicon Endo-Surgery, Inc. Coupling arrangements and methods for attaching tools to ultrasonic surgical instruments
US8663220B2 (en) 2009-07-15 2014-03-04 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments
US8956349B2 (en) 2009-10-09 2015-02-17 Ethicon Endo-Surgery, Inc. Surgical generator for ultrasonic and electrosurgical devices
US11090104B2 (en) 2009-10-09 2021-08-17 Cilag Gmbh International Surgical generator for ultrasonic and electrosurgical devices
US10441345B2 (en) 2009-10-09 2019-10-15 Ethicon Llc Surgical generator for ultrasonic and electrosurgical devices
US8469981B2 (en) 2010-02-11 2013-06-25 Ethicon Endo-Surgery, Inc. Rotatable cutting implement arrangements for ultrasonic surgical instruments
US8486096B2 (en) 2010-02-11 2013-07-16 Ethicon Endo-Surgery, Inc. Dual purpose surgical instrument for cutting and coagulating tissue
US8951272B2 (en) 2010-02-11 2015-02-10 Ethicon Endo-Surgery, Inc. Seal arrangements for ultrasonically powered surgical instruments
DE102010018679A1 (en) * 2010-04-28 2011-11-03 Medizinisches Laserzentrum Lübeck GmbH Device with OCT system for examination and treatment of living tissue under heating by absorption of electromagnetic radiation
US8795327B2 (en) 2010-07-22 2014-08-05 Ethicon Endo-Surgery, Inc. Electrosurgical instrument with separate closure and cutting members
US9192431B2 (en) 2010-07-23 2015-11-24 Ethicon Endo-Surgery, Inc. Electrosurgical cutting and sealing instrument
US9259265B2 (en) 2011-07-22 2016-02-16 Ethicon Endo-Surgery, Llc Surgical instruments for tensioning tissue
EP2811932B1 (en) 2012-02-10 2019-06-26 Ethicon LLC Robotically controlled surgical instrument
US9439668B2 (en) 2012-04-09 2016-09-13 Ethicon Endo-Surgery, Llc Switch arrangements for ultrasonic surgical instruments
US20140005705A1 (en) 2012-06-29 2014-01-02 Ethicon Endo-Surgery, Inc. Surgical instruments with articulating shafts
US9820768B2 (en) 2012-06-29 2017-11-21 Ethicon Llc Ultrasonic surgical instruments with control mechanisms
US20140005702A1 (en) 2012-06-29 2014-01-02 Ethicon Endo-Surgery, Inc. Ultrasonic surgical instruments with distally positioned transducers
US9326788B2 (en) 2012-06-29 2016-05-03 Ethicon Endo-Surgery, Llc Lockout mechanism for use with robotic electrosurgical device
US9351754B2 (en) 2012-06-29 2016-05-31 Ethicon Endo-Surgery, Llc Ultrasonic surgical instruments with distally positioned jaw assemblies
US9226767B2 (en) 2012-06-29 2016-01-05 Ethicon Endo-Surgery, Inc. Closed feedback control for electrosurgical device
US9408622B2 (en) 2012-06-29 2016-08-09 Ethicon Endo-Surgery, Llc Surgical instruments with articulating shafts
US9393037B2 (en) 2012-06-29 2016-07-19 Ethicon Endo-Surgery, Llc Surgical instruments with articulating shafts
US9198714B2 (en) 2012-06-29 2015-12-01 Ethicon Endo-Surgery, Inc. Haptic feedback devices for surgical robot
US8913251B2 (en) * 2012-08-27 2014-12-16 Canon Kabushiki Kaisha Estimating material properties using speckle statistics
BR112015007010B1 (en) 2012-09-28 2022-05-31 Ethicon Endo-Surgery, Inc end actuator
US9095367B2 (en) 2012-10-22 2015-08-04 Ethicon Endo-Surgery, Inc. Flexible harmonic waveguides/blades for surgical instruments
US20140135804A1 (en) 2012-11-15 2014-05-15 Ethicon Endo-Surgery, Inc. Ultrasonic and electrosurgical devices
US10226273B2 (en) 2013-03-14 2019-03-12 Ethicon Llc Mechanical fasteners for use with surgical energy devices
WO2014151808A1 (en) * 2013-03-14 2014-09-25 Volcano Corporation Parallelized tree-based pattern recognition for tissue characterization
WO2014205281A2 (en) 2013-06-19 2014-12-24 The General Hospital Corporation Omni-directional viewing apparatus
US9814514B2 (en) 2013-09-13 2017-11-14 Ethicon Llc Electrosurgical (RF) medical instruments for cutting and coagulating tissue
US9265926B2 (en) 2013-11-08 2016-02-23 Ethicon Endo-Surgery, Llc Electrosurgical devices
GB2521229A (en) 2013-12-16 2015-06-17 Ethicon Endo Surgery Inc Medical device
GB2521228A (en) 2013-12-16 2015-06-17 Ethicon Endo Surgery Inc Medical device
US20150185131A1 (en) * 2013-12-26 2015-07-02 National Cheng Kung University Method and device for measuring the liquid viscosity
US9795436B2 (en) 2014-01-07 2017-10-24 Ethicon Llc Harvesting energy from a surgical generator
EP3100043A4 (en) 2014-01-31 2017-09-13 The General Hospital Corporation System and methods for estimation of mechanical properties and size of light-scattering particles in materials
US9554854B2 (en) 2014-03-18 2017-01-31 Ethicon Endo-Surgery, Llc Detecting short circuits in electrosurgical medical devices
US10092310B2 (en) 2014-03-27 2018-10-09 Ethicon Llc Electrosurgical devices
US10463421B2 (en) 2014-03-27 2019-11-05 Ethicon Llc Two stage trigger, clamp and cut bipolar vessel sealer
US9737355B2 (en) 2014-03-31 2017-08-22 Ethicon Llc Controlling impedance rise in electrosurgical medical devices
US9913680B2 (en) 2014-04-15 2018-03-13 Ethicon Llc Software algorithms for electrosurgical instruments
US10285724B2 (en) 2014-07-31 2019-05-14 Ethicon Llc Actuation mechanisms and load adjustment assemblies for surgical instruments
KR102299361B1 (en) 2014-09-03 2021-09-07 삼성전자주식회사 Apparatus and method for monitoring blood pressure, wearable device having function of blood pressure monitoring
US10639092B2 (en) 2014-12-08 2020-05-05 Ethicon Llc Electrode configurations for surgical instruments
KR102411658B1 (en) 2015-01-15 2022-06-21 삼성전자주식회사 Apparatus for detecting information of the living body
US10070796B2 (en) * 2015-02-04 2018-09-11 General Electric Company Systems and methods for quantitative microcirculation state monitoring
US10245095B2 (en) 2015-02-06 2019-04-02 Ethicon Llc Electrosurgical instrument with rotation and articulation mechanisms
KR102384225B1 (en) 2015-03-06 2022-04-07 삼성전자주식회사 System and method for sensing blood pressure
US10342602B2 (en) 2015-03-17 2019-07-09 Ethicon Llc Managing tissue treatment
US10321950B2 (en) 2015-03-17 2019-06-18 Ethicon Llc Managing tissue treatment
US10595929B2 (en) 2015-03-24 2020-03-24 Ethicon Llc Surgical instruments with firing system overload protection mechanisms
JP2016217860A (en) * 2015-05-20 2016-12-22 キヤノン株式会社 Control device, measuring device, control method, program, and storage medium
US10542961B2 (en) 2015-06-15 2020-01-28 The Research Foundation For The State University Of New York System and method for infrasonic cardiac monitoring
US11020140B2 (en) 2015-06-17 2021-06-01 Cilag Gmbh International Ultrasonic surgical blade for use with ultrasonic surgical instruments
US11141213B2 (en) 2015-06-30 2021-10-12 Cilag Gmbh International Surgical instrument with user adaptable techniques
US10357303B2 (en) 2015-06-30 2019-07-23 Ethicon Llc Translatable outer tube for sealing using shielded lap chole dissector
US11051873B2 (en) 2015-06-30 2021-07-06 Cilag Gmbh International Surgical system with user adaptable techniques employing multiple energy modalities based on tissue parameters
US11129669B2 (en) 2015-06-30 2021-09-28 Cilag Gmbh International Surgical system with user adaptable techniques based on tissue type
US10898256B2 (en) 2015-06-30 2021-01-26 Ethicon Llc Surgical system with user adaptable techniques based on tissue impedance
US10034704B2 (en) 2015-06-30 2018-07-31 Ethicon Llc Surgical instrument with user adaptable algorithms
US10154852B2 (en) 2015-07-01 2018-12-18 Ethicon Llc Ultrasonic surgical blade with improved cutting and coagulation features
KR102434701B1 (en) 2015-09-01 2022-08-22 삼성전자주식회사 Apparatus and method for acquiring bio- information and apparatus for detecting bio- information
US10687884B2 (en) 2015-09-30 2020-06-23 Ethicon Llc Circuits for supplying isolated direct current (DC) voltage to surgical instruments
US10595930B2 (en) 2015-10-16 2020-03-24 Ethicon Llc Electrode wiping surgical device
WO2017086719A1 (en) * 2015-11-17 2017-05-26 한국과학기술원 Apparatus for detecting sample properties using chaotic wave sensor
CN108474740B (en) 2015-11-17 2021-03-02 韩国科学技术院 Sample characteristic detection device using chaotic wave sensor
US10179022B2 (en) 2015-12-30 2019-01-15 Ethicon Llc Jaw position impedance limiter for electrosurgical instrument
US10575892B2 (en) 2015-12-31 2020-03-03 Ethicon Llc Adapter for electrical surgical instruments
US10716615B2 (en) 2016-01-15 2020-07-21 Ethicon Llc Modular battery powered handheld surgical instrument with curved end effectors having asymmetric engagement between jaw and blade
US11229471B2 (en) 2016-01-15 2022-01-25 Cilag Gmbh International Modular battery powered handheld surgical instrument with selective application of energy based on tissue characterization
US10709469B2 (en) 2016-01-15 2020-07-14 Ethicon Llc Modular battery powered handheld surgical instrument with energy conservation techniques
US11129670B2 (en) 2016-01-15 2021-09-28 Cilag Gmbh International Modular battery powered handheld surgical instrument with selective application of energy based on button displacement, intensity, or local tissue characterization
US11150173B2 (en) * 2016-02-12 2021-10-19 The General Hospital Corporation Laser speckle micro-rheology in characterization of biomechanical properties of tissues
US10555769B2 (en) 2016-02-22 2020-02-11 Ethicon Llc Flexible circuits for electrosurgical instrument
US10646269B2 (en) 2016-04-29 2020-05-12 Ethicon Llc Non-linear jaw gap for electrosurgical instruments
US10485607B2 (en) 2016-04-29 2019-11-26 Ethicon Llc Jaw structure with distal closure for electrosurgical instruments
US10702329B2 (en) 2016-04-29 2020-07-07 Ethicon Llc Jaw structure with distal post for electrosurgical instruments
US10456193B2 (en) 2016-05-03 2019-10-29 Ethicon Llc Medical device with a bilateral jaw configuration for nerve stimulation
GB201610594D0 (en) * 2016-06-17 2016-08-03 Ucl Business Plc Method and apparatus for estimating the value of a physical parameter in a biological tissue
US10245064B2 (en) 2016-07-12 2019-04-02 Ethicon Llc Ultrasonic surgical instrument with piezoelectric central lumen transducer
US10893883B2 (en) 2016-07-13 2021-01-19 Ethicon Llc Ultrasonic assembly for use with ultrasonic surgical instruments
US10842522B2 (en) 2016-07-15 2020-11-24 Ethicon Llc Ultrasonic surgical instruments having offset blades
US10376305B2 (en) 2016-08-05 2019-08-13 Ethicon Llc Methods and systems for advanced harmonic energy
US10285723B2 (en) 2016-08-09 2019-05-14 Ethicon Llc Ultrasonic surgical blade with improved heel portion
USD847990S1 (en) 2016-08-16 2019-05-07 Ethicon Llc Surgical instrument
US10952759B2 (en) 2016-08-25 2021-03-23 Ethicon Llc Tissue loading of a surgical instrument
US10828056B2 (en) 2016-08-25 2020-11-10 Ethicon Llc Ultrasonic transducer to waveguide acoustic coupling, connections, and configurations
CN107928643B (en) 2016-10-12 2022-04-01 三星电子株式会社 Apparatus and method for estimating biometric information
JP2018094395A (en) * 2016-11-03 2018-06-21 キヤノン ユーエスエイ, インコーポレイテッドCanon U.S.A., Inc Diagnostic spectrally encoded endoscopy apparatuses and systems, and methods for use with the same
US10603064B2 (en) 2016-11-28 2020-03-31 Ethicon Llc Ultrasonic transducer
US11266430B2 (en) 2016-11-29 2022-03-08 Cilag Gmbh International End effector control and calibration
US20180172425A1 (en) * 2016-12-21 2018-06-21 The Penn State Research Foundation High definition optical coherence tomography imaging for non-invasive examination of heritage works
US10820920B2 (en) 2017-07-05 2020-11-03 Ethicon Llc Reusable ultrasonic medical devices and methods of their use
US11812957B2 (en) 2019-12-30 2023-11-14 Cilag Gmbh International Surgical instrument comprising a signal interference resolution system
US11786291B2 (en) 2019-12-30 2023-10-17 Cilag Gmbh International Deflectable support of RF energy electrode with respect to opposing ultrasonic blade
US11937863B2 (en) 2019-12-30 2024-03-26 Cilag Gmbh International Deflectable electrode with variable compression bias along the length of the deflectable electrode
US20210196363A1 (en) 2019-12-30 2021-07-01 Ethicon Llc Electrosurgical instrument with electrodes operable in bipolar and monopolar modes
US20210196359A1 (en) 2019-12-30 2021-07-01 Ethicon Llc Electrosurgical instruments with electrodes having energy focusing features
US11911063B2 (en) 2019-12-30 2024-02-27 Cilag Gmbh International Techniques for detecting ultrasonic blade to electrode contact and reducing power to ultrasonic blade
US20210196344A1 (en) 2019-12-30 2021-07-01 Ethicon Llc Surgical system communication pathways
US11779387B2 (en) 2019-12-30 2023-10-10 Cilag Gmbh International Clamp arm jaw to minimize tissue sticking and improve tissue control
US11696776B2 (en) 2019-12-30 2023-07-11 Cilag Gmbh International Articulatable surgical instrument
US11660089B2 (en) 2019-12-30 2023-05-30 Cilag Gmbh International Surgical instrument comprising a sensing system
US11779329B2 (en) 2019-12-30 2023-10-10 Cilag Gmbh International Surgical instrument comprising a flex circuit including a sensor system
US11452525B2 (en) 2019-12-30 2022-09-27 Cilag Gmbh International Surgical instrument comprising an adjustment system
US11684412B2 (en) 2019-12-30 2023-06-27 Cilag Gmbh International Surgical instrument with rotatable and articulatable surgical end effector
US11944366B2 (en) 2019-12-30 2024-04-02 Cilag Gmbh International Asymmetric segmented ultrasonic support pad for cooperative engagement with a movable RF electrode
US11950797B2 (en) 2019-12-30 2024-04-09 Cilag Gmbh International Deflectable electrode with higher distal bias relative to proximal bias
US20210196349A1 (en) 2019-12-30 2021-07-01 Ethicon Llc Electrosurgical instrument with flexible wiring assemblies

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036015A1 (en) * 2000-10-30 2002-05-10 The General Hospital Corporation Optical methods and systems for tissue analysis
US20040068163A1 (en) * 2001-01-26 2004-04-08 Ruchti Timothy L. Noninvasive measurement of glucose through the optical properties of tissue
US7365859B2 (en) * 2004-09-10 2008-04-29 The General Hospital Corporation System and method for optical coherence imaging
WO2008121844A1 (en) * 2007-03-30 2008-10-09 The General Hospital Corporation System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque

Family Cites Families (392)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2339754A (en) 1941-03-04 1944-01-25 Westinghouse Electric & Mfg Co Supervisory apparatus
US3090753A (en) 1960-08-02 1963-05-21 Exxon Research Engineering Co Ester oil compositions containing acid anhydride
GB1257778A (en) 1967-12-07 1971-12-22
US3601480A (en) 1968-07-10 1971-08-24 Physics Int Co Optical tunnel high-speed camera system
JPS4932484U (en) 1972-06-19 1974-03-20
US3872407A (en) 1972-09-01 1975-03-18 Us Navy Rapidly tunable laser
JPS584481Y2 (en) 1973-06-23 1983-01-26 オリンパス光学工業株式会社 Naishikiyoushiyahenkankogakkei
FR2253410A5 (en) 1973-12-03 1975-06-27 Inst Nat Sante Rech Med
US3941121A (en) 1974-12-20 1976-03-02 The University Of Cincinnati Focusing fiber-optic needle endoscope
US3983507A (en) 1975-01-06 1976-09-28 Research Corporation Tunable laser systems and method
US3973219A (en) 1975-04-24 1976-08-03 Cornell Research Foundation, Inc. Very rapidly tuned cw dye laser
US4030831A (en) 1976-03-22 1977-06-21 The United States Of America As Represented By The Secretary Of The Navy Phase detector for optical figure sensing
US4141362A (en) 1977-05-23 1979-02-27 Richard Wolf Gmbh Laser endoscope
US4224929A (en) 1977-11-08 1980-09-30 Olympus Optical Co., Ltd. Endoscope with expansible cuff member and operation section
DE2964775D1 (en) 1978-03-09 1983-03-24 Nat Res Dev Measurement of small movements
GB2030313A (en) 1978-06-29 1980-04-02 Wolf Gmbh Richard Endoscopes
FR2448728A1 (en) 1979-02-07 1980-09-05 Thomson Csf ROTATING JOINT DEVICE FOR OPTICAL CONDUCTOR CONNECTION AND SYSTEM COMPRISING SUCH A DEVICE
US4295738A (en) 1979-08-30 1981-10-20 United Technologies Corporation Fiber optic strain sensor
US4300816A (en) 1979-08-30 1981-11-17 United Technologies Corporation Wide band multicore optical fiber
US4428643A (en) 1981-04-08 1984-01-31 Xerox Corporation Optical scanning system with wavelength shift correction
US5065331A (en) 1981-05-18 1991-11-12 Vachon Reginald I Apparatus and method for determining the stress and strain in pipes, pressure vessels, structural members and other deformable bodies
GB2106736B (en) 1981-09-03 1985-06-12 Standard Telephones Cables Ltd Optical transmission system
US4479499A (en) 1982-01-29 1984-10-30 Alfano Robert R Method and apparatus for detecting the presence of caries in teeth using visible light
US4601036A (en) 1982-09-30 1986-07-15 Honeywell Inc. Rapidly tunable laser
HU187188B (en) 1982-11-25 1985-11-28 Koezponti Elelmiszeripari Device for generating radiation of controllable spectral structure
CH663466A5 (en) 1983-09-12 1987-12-15 Battelle Memorial Institute METHOD AND DEVICE FOR DETERMINING THE POSITION OF AN OBJECT IN RELATION TO A REFERENCE.
US5318024A (en) 1985-03-22 1994-06-07 Massachusetts Institute Of Technology Laser endoscope for spectroscopic imaging
EP0590268B1 (en) 1985-03-22 1998-07-01 Massachusetts Institute Of Technology Fiber Optic Probe System for Spectrally Diagnosing Tissue
US4607622A (en) 1985-04-11 1986-08-26 Charles D. Fritch Fiber optic ocular endoscope
US4631498A (en) 1985-04-26 1986-12-23 Hewlett-Packard Company CW Laser wavemeter/frequency locking technique
US4650327A (en) 1985-10-28 1987-03-17 Oximetrix, Inc. Optical catheter calibrating assembly
US5040889A (en) 1986-05-30 1991-08-20 Pacific Scientific Company Spectrometer with combined visible and ultraviolet sample illumination
CA1290019C (en) 1986-06-20 1991-10-01 Hideo Kuwahara Dual balanced optical signal receiver
US4770492A (en) 1986-10-28 1988-09-13 Spectran Corporation Pressure or strain sensitive optical fiber
JPH0824665B2 (en) 1986-11-28 1996-03-13 オリンパス光学工業株式会社 Endoscope device
US4744656A (en) 1986-12-08 1988-05-17 Spectramed, Inc. Disposable calibration boot for optical-type cardiovascular catheter
US4751706A (en) 1986-12-31 1988-06-14 The United States Of America As Represented By The Secretary Of The Army Laser for providing rapid sequence of different wavelengths
US4834111A (en) 1987-01-12 1989-05-30 The Trustees Of Columbia University In The City Of New York Heterodyne interferometer
GB2209221B (en) 1987-09-01 1991-10-23 Litton Systems Inc Hydrophone demodulator circuit and method
US4909631A (en) 1987-12-18 1990-03-20 Tan Raul Y Method for film thickness and refractive index determination
US4890901A (en) 1987-12-22 1990-01-02 Hughes Aircraft Company Color corrector for embedded prisms
US4892406A (en) 1988-01-11 1990-01-09 United Technologies Corporation Method of and arrangement for measuring vibrations
FR2626367B1 (en) 1988-01-25 1990-05-11 Thomson Csf MULTI-POINT FIBER OPTIC TEMPERATURE SENSOR
FR2626383B1 (en) 1988-01-27 1991-10-25 Commissariat Energie Atomique EXTENDED FIELD SCAN AND DEPTH CONFOCAL OPTICAL MICROSCOPY AND DEVICES FOR CARRYING OUT THE METHOD
US4925302A (en) 1988-04-13 1990-05-15 Hewlett-Packard Company Frequency locking device
US4998972A (en) 1988-04-28 1991-03-12 Thomas J. Fogarty Real time angioscopy imaging system
US5730731A (en) 1988-04-28 1998-03-24 Thomas J. Fogarty Pressure-based irrigation accumulator
US4905169A (en) 1988-06-02 1990-02-27 The United States Of America As Represented By The United States Department Of Energy Method and apparatus for simultaneously measuring a plurality of spectral wavelengths present in electromagnetic radiation
US5242437A (en) 1988-06-10 1993-09-07 Trimedyne Laser Systems, Inc. Medical device applying localized high intensity light and heat, particularly for destruction of the endometrium
DE68929464T2 (en) 1988-07-13 2003-11-20 Optiscan Pty Ltd scanning microscope
GB8817672D0 (en) 1988-07-25 1988-09-01 Sira Ltd Optical apparatus
US5214538A (en) 1988-07-25 1993-05-25 Keymed (Medical And Industrial Equipment) Limited Optical apparatus
US4868834A (en) 1988-09-14 1989-09-19 The United States Of America As Represented By The Secretary Of The Army System for rapidly tuning a low pressure pulsed laser
DE3833602A1 (en) 1988-10-03 1990-02-15 Krupp Gmbh SPECTROMETER FOR SIMULTANEOUS INTENSITY MEASUREMENT IN DIFFERENT SPECTRAL AREAS
US5419323A (en) 1988-12-21 1995-05-30 Massachusetts Institute Of Technology Method for laser induced fluorescence of tissue
US5046501A (en) 1989-01-18 1991-09-10 Wayne State University Atherosclerotic identification
US5085496A (en) 1989-03-31 1992-02-04 Sharp Kabushiki Kaisha Optical element and optical pickup device comprising it
US5317389A (en) 1989-06-12 1994-05-31 California Institute Of Technology Method and apparatus for white-light dispersed-fringe interferometric measurement of corneal topography
US4965599A (en) 1989-11-13 1990-10-23 Eastman Kodak Company Scanning apparatus for halftone image screen writing
US5133035A (en) 1989-11-14 1992-07-21 Hicks John W Multifiber endoscope with multiple scanning modes to produce an image free of fixed pattern noise
KR930003307B1 (en) 1989-12-14 1993-04-24 주식회사 금성사 Three dimensional projector
DD293205B5 (en) 1990-03-05 1995-06-29 Zeiss Carl Jena Gmbh Optical fiber guide for a medical observation device
US5039193A (en) 1990-04-03 1991-08-13 Focal Technologies Incorporated Fibre optic single mode rotary joint
US5262644A (en) 1990-06-29 1993-11-16 Southwest Research Institute Remote spectroscopy for raman and brillouin scattering
US5197470A (en) 1990-07-16 1993-03-30 Eastman Kodak Company Near infrared diagnostic method and instrument
GB9015793D0 (en) 1990-07-18 1990-09-05 Medical Res Council Confocal scanning optical microscope
US5127730A (en) 1990-08-10 1992-07-07 Regents Of The University Of Minnesota Multi-color laser scanning confocal imaging system
US5845639A (en) 1990-08-10 1998-12-08 Board Of Regents Of The University Of Washington Optical imaging methods
US5305759A (en) 1990-09-26 1994-04-26 Olympus Optical Co., Ltd. Examined body interior information observing apparatus by using photo-pulses controlling gains for depths
US5241364A (en) 1990-10-19 1993-08-31 Fuji Photo Film Co., Ltd. Confocal scanning type of phase contrast microscope and scanning microscope
US5250186A (en) 1990-10-23 1993-10-05 Cetus Corporation HPLC light scattering detector for biopolymers
US5202745A (en) 1990-11-07 1993-04-13 Hewlett-Packard Company Polarization independent optical coherence-domain reflectometry
US5275594A (en) 1990-11-09 1994-01-04 C. R. Bard, Inc. Angioplasty system having means for identification of atherosclerotic plaque
JP3035336B2 (en) 1990-11-27 2000-04-24 興和株式会社 Blood flow measurement device
US5228001A (en) 1991-01-23 1993-07-13 Syracuse University Optical random access memory
US6198532B1 (en) 1991-02-22 2001-03-06 Applied Spectral Imaging Ltd. Spectral bio-imaging of the eye
US5293872A (en) 1991-04-03 1994-03-15 Alfano Robert R Method for distinguishing between calcified atherosclerotic tissue and fibrous atherosclerotic tissue or normal cardiovascular tissue using Raman spectroscopy
US5321501A (en) 1991-04-29 1994-06-14 Massachusetts Institute Of Technology Method and apparatus for optical imaging with means for controlling the longitudinal range of the sample
US6134003A (en) 1991-04-29 2000-10-17 Massachusetts Institute Of Technology Method and apparatus for performing optical measurements using a fiber optic imaging guidewire, catheter or endoscope
US5748598A (en) 1995-12-22 1998-05-05 Massachusetts Institute Of Technology Apparatus and methods for reading multilayer storage media using short coherence length sources
US6485413B1 (en) 1991-04-29 2002-11-26 The General Hospital Corporation Methods and apparatus for forward-directed optical scanning instruments
US5465147A (en) 1991-04-29 1995-11-07 Massachusetts Institute Of Technology Method and apparatus for acquiring images using a ccd detector array and no transverse scanner
US6501551B1 (en) 1991-04-29 2002-12-31 Massachusetts Institute Of Technology Fiber optic imaging endoscope interferometer with at least one faraday rotator
US6564087B1 (en) 1991-04-29 2003-05-13 Massachusetts Institute Of Technology Fiber optic needle probes for optical coherence tomography imaging
US5956355A (en) 1991-04-29 1999-09-21 Massachusetts Institute Of Technology Method and apparatus for performing optical measurements using a rapidly frequency-tuned laser
US6111645A (en) 1991-04-29 2000-08-29 Massachusetts Institute Of Technology Grating based phase control optical delay line
US5441053A (en) 1991-05-03 1995-08-15 University Of Kentucky Research Foundation Apparatus and method for multiple wavelength of tissue
US5208651A (en) 1991-07-16 1993-05-04 The Regents Of The University Of California Apparatus and method for measuring fluorescence intensities at a plurality of wavelengths and lifetimes
WO1993003672A1 (en) 1991-08-20 1993-03-04 Redd Douglas C B Optical histochemical analysis, in vivo detection and real-time guidance for ablation of abnormal tissues using a raman spectroscopic detection system
DE4128744C1 (en) 1991-08-29 1993-04-22 Siemens Ag, 8000 Muenchen, De
US5353790A (en) 1992-01-17 1994-10-11 Board Of Regents, The University Of Texas System Method and apparatus for optical measurement of bilirubin in tissue
US5212667A (en) 1992-02-03 1993-05-18 General Electric Company Light imaging in a scattering medium, using ultrasonic probing and speckle image differencing
US5248876A (en) 1992-04-21 1993-09-28 International Business Machines Corporation Tandem linear scanning confocal imaging system with focal volumes at different heights
US5486701A (en) 1992-06-16 1996-01-23 Prometrix Corporation Method and apparatus for measuring reflectance in two wavelength bands to enable determination of thin film thickness
US5716324A (en) 1992-08-25 1998-02-10 Fuji Photo Film Co., Ltd. Endoscope with surface and deep portion imaging systems
US5348003A (en) 1992-09-03 1994-09-20 Sirraya, Inc. Method and apparatus for chemical analysis
US5698397A (en) 1995-06-07 1997-12-16 Sri International Up-converting reporters for biological and other assays using laser excitation techniques
US5772597A (en) 1992-09-14 1998-06-30 Sextant Medical Corporation Surgical tool end effector
US5383467A (en) 1992-11-18 1995-01-24 Spectrascience, Inc. Guidewire catheter and apparatus for diagnostic imaging
US5439000A (en) 1992-11-18 1995-08-08 Spectrascience, Inc. Method of diagnosing tissue with guidewire
US5987346A (en) 1993-02-26 1999-11-16 Benaron; David A. Device and method for classification of tissue
JP3112595B2 (en) 1993-03-17 2000-11-27 安藤電気株式会社 Optical fiber strain position measuring device using optical frequency shifter
FI93781C (en) 1993-03-18 1995-05-26 Wallac Oy Biospecific multiparametric assay method
DE4309056B4 (en) 1993-03-20 2006-05-24 Häusler, Gerd, Prof. Dr. Method and device for determining the distance and scattering intensity of scattering points
US5485079A (en) 1993-03-29 1996-01-16 Matsushita Electric Industrial Co., Ltd. Magneto-optical element and optical magnetic field sensor
DE4310209C2 (en) 1993-03-29 1996-05-30 Bruker Medizintech Optical stationary imaging in strongly scattering media
DE4314189C1 (en) 1993-04-30 1994-11-03 Bodenseewerk Geraetetech Device for the examination of optical fibres made of glass by means of heterodyne Brillouin spectroscopy
US5454807A (en) 1993-05-14 1995-10-03 Boston Scientific Corporation Medical treatment of deeply seated tissue using optical radiation
EP0627643B1 (en) 1993-06-03 1999-05-06 Hamamatsu Photonics K.K. Laser scanning optical system using axicon
JP3234353B2 (en) 1993-06-15 2001-12-04 富士写真フイルム株式会社 Tomographic information reader
US5803082A (en) 1993-11-09 1998-09-08 Staplevision Inc. Omnispectramammography
US5983125A (en) 1993-12-13 1999-11-09 The Research Foundation Of City College Of New York Method and apparatus for in vivo examination of subcutaneous tissues inside an organ of a body using optical spectroscopy
US5450203A (en) 1993-12-22 1995-09-12 Electroglas, Inc. Method and apparatus for determining an objects position, topography and for imaging
US5411016A (en) 1994-02-22 1995-05-02 Scimed Life Systems, Inc. Intravascular balloon catheter for use in combination with an angioscope
US5590660A (en) 1994-03-28 1997-01-07 Xillix Technologies Corp. Apparatus and method for imaging diseased tissue using integrated autofluorescence
DE4411017C2 (en) 1994-03-30 1995-06-08 Alexander Dr Knuettel Optical stationary spectroscopic imaging in strongly scattering objects through special light focusing and signal detection of light of different wavelengths
TW275570B (en) 1994-05-05 1996-05-11 Boehringer Mannheim Gmbh
US5459325A (en) 1994-07-19 1995-10-17 Molecular Dynamics, Inc. High-speed fluorescence scanner
US6159445A (en) 1994-07-20 2000-12-12 Nycomed Imaging As Light imaging contrast agents
DE69533903T2 (en) 1994-08-18 2005-12-08 Carl Zeiss Meditec Ag Surgical apparatus controlled by optical coherence tomography
US5491524A (en) 1994-10-05 1996-02-13 Carl Zeiss, Inc. Optical coherence tomography corneal mapping apparatus
US5740808A (en) 1996-10-28 1998-04-21 Ep Technologies, Inc Systems and methods for guilding diagnostic or therapeutic devices in interior tissue regions
US5817144A (en) 1994-10-25 1998-10-06 Latis, Inc. Method for contemporaneous application OF laser energy and localized pharmacologic therapy
US6033721A (en) 1994-10-26 2000-03-07 Revise, Inc. Image-based three-axis positioner for laser direct write microchemical reaction
US5566267A (en) 1994-12-15 1996-10-15 Ceram Optec Industries Inc. Flat surfaced optical fibers and diode laser medical delivery devices
US5600486A (en) 1995-01-30 1997-02-04 Lockheed Missiles And Space Company, Inc. Color separation microlens
US5648848A (en) 1995-02-01 1997-07-15 Nikon Precision, Inc. Beam delivery apparatus and method for interferometry using rotatable polarization chucks
DE19506484C2 (en) 1995-02-24 1999-09-16 Stiftung Fuer Lasertechnologie Method and device for selective non-invasive laser myography (LMG)
RU2100787C1 (en) 1995-03-01 1997-12-27 Геликонов Валентин Михайлович Fibre-optical interferometer and fiber-optical piezoelectric transducer
WO1996028212A1 (en) 1995-03-09 1996-09-19 Innotech Usa, Inc. Laser surgical device and method of its use
US5526338A (en) 1995-03-10 1996-06-11 Yeda Research & Development Co. Ltd. Method and apparatus for storage and retrieval with multilayer optical disks
US5697373A (en) 1995-03-14 1997-12-16 Board Of Regents, The University Of Texas System Optical method and apparatus for the diagnosis of cervical precancers using raman and fluorescence spectroscopies
US5735276A (en) 1995-03-21 1998-04-07 Lemelson; Jerome Method and apparatus for scanning and evaluating matter
DE19681304T1 (en) 1995-03-24 1998-04-16 Optiscan Pty Ltd Confocal imaging system with optical fiber and variable close confocal control
US5621830A (en) 1995-06-07 1997-04-15 Smith & Nephew Dyonics Inc. Rotatable fiber optic joint
US5785651A (en) 1995-06-07 1998-07-28 Keravision, Inc. Distance measuring confocal microscope
WO1997001167A1 (en) 1995-06-21 1997-01-09 Massachusetts Institute Of Technology Apparatus and method for accessing data on multilayered optical media
ATA107495A (en) 1995-06-23 1996-06-15 Fercher Adolf Friedrich Dr COHERENCE BIOMETRY AND TOMOGRAPHY WITH DYNAMIC COHERENT FOCUS
JP3819032B2 (en) 1995-08-24 2006-09-06 ザ・テキサス・エイ・アンド・エム・ユニバーシティ・システム Imaging and spectroscopic analysis based on fluorescence lifetime in tissues and other random media
US6016197A (en) 1995-08-25 2000-01-18 Ceramoptec Industries Inc. Compact, all-optical spectrum analyzer for chemical and biological fiber optic sensors
FR2738343B1 (en) 1995-08-30 1997-10-24 Cohen Sabban Joseph OPTICAL MICROSTRATIGRAPHY DEVICE
DE69622764T2 (en) 1995-09-20 2003-04-24 Texas Heart Inst Houston y DISPLAY OF THERMAL DISCONTINUITY ON VESSEL WALLS
US6615071B1 (en) 1995-09-20 2003-09-02 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
US6763261B2 (en) 1995-09-20 2004-07-13 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
DE19542955C2 (en) 1995-11-17 1999-02-18 Schwind Gmbh & Co Kg Herbert endoscope
US5719399A (en) 1995-12-18 1998-02-17 The Research Foundation Of City College Of New York Imaging and characterization of tissue based upon the preservation of polarized light transmitted therethrough
US5748318A (en) 1996-01-23 1998-05-05 Brown University Research Foundation Optical stress generator and detector
US5840023A (en) 1996-01-31 1998-11-24 Oraevsky; Alexander A. Optoacoustic imaging for medical diagnosis
US5642194A (en) 1996-02-05 1997-06-24 The Regents Of The University Of California White light velocity interferometer
US5862273A (en) 1996-02-23 1999-01-19 Kaiser Optical Systems, Inc. Fiber optic probe with integral optical filtering
US5843000A (en) 1996-05-07 1998-12-01 The General Hospital Corporation Optical biopsy forceps and method of diagnosing tissue
ATA84696A (en) 1996-05-14 1998-03-15 Adolf Friedrich Dr Fercher METHOD AND ARRANGEMENTS FOR INCREASING CONTRAST IN OPTICAL COHERENCE TOMOGRAPHY
US6020963A (en) 1996-06-04 2000-02-01 Northeastern University Optical quadrature Interferometer
US5795295A (en) 1996-06-25 1998-08-18 Carl Zeiss, Inc. OCT-assisted surgical microscope with multi-coordinate manipulator
US5842995A (en) 1996-06-28 1998-12-01 Board Of Regents, The Univerisity Of Texas System Spectroscopic probe for in vivo measurement of raman signals
US6296608B1 (en) 1996-07-08 2001-10-02 Boston Scientific Corporation Diagnosing and performing interventional procedures on tissue in vivo
US6245026B1 (en) 1996-07-29 2001-06-12 Farallon Medsystems, Inc. Thermography catheter
US5840075A (en) 1996-08-23 1998-11-24 Eclipse Surgical Technologies, Inc. Dual laser device for transmyocardial revascularization procedures
US6396941B1 (en) 1996-08-23 2002-05-28 Bacus Research Laboratories, Inc. Method and apparatus for internet, intranet, and local viewing of virtual microscope slides
JPH1090603A (en) 1996-09-18 1998-04-10 Olympus Optical Co Ltd Endscopic optical system
EP0928433A1 (en) 1996-09-27 1999-07-14 Vincent Lauer Microscope generating a three-dimensional representation of an object
DE19640495C2 (en) 1996-10-01 1999-12-16 Leica Microsystems Device for confocal surface measurement
US5843052A (en) 1996-10-04 1998-12-01 Benja-Athon; Anuthep Irrigation kit for application of fluids and chemicals for cleansing and sterilizing wounds
US6044288A (en) 1996-11-08 2000-03-28 Imaging Diagnostics Systems, Inc. Apparatus and method for determining the perimeter of the surface of an object being scanned
US5872879A (en) 1996-11-25 1999-02-16 Boston Scientific Corporation Rotatable connecting optical fibers
US6517532B1 (en) 1997-05-15 2003-02-11 Palomar Medical Technologies, Inc. Light energy delivery head
US5871449A (en) 1996-12-27 1999-02-16 Brown; David Lloyd Device and method for locating inflamed plaque in an artery
US5991697A (en) 1996-12-31 1999-11-23 The Regents Of The University Of California Method and apparatus for optical Doppler tomographic imaging of fluid flow velocity in highly scattering media
US5760901A (en) 1997-01-28 1998-06-02 Zetetic Institute Method and apparatus for confocal interference microscopy with background amplitude reduction and compensation
US5801826A (en) 1997-02-18 1998-09-01 Williams Family Trust B Spectrometric device and method for recognizing atomic and molecular signatures
US6120516A (en) 1997-02-28 2000-09-19 Lumend, Inc. Method for treating vascular occlusion
US5968064A (en) 1997-02-28 1999-10-19 Lumend, Inc. Catheter system for treating a vascular occlusion
US6010449A (en) 1997-02-28 2000-01-04 Lumend, Inc. Intravascular catheter system for treating a vascular occlusion
JP2001515382A (en) 1997-03-06 2001-09-18 マサチューセッツ インスティチュート オブ テクノロジー Equipment for optical scanning of living tissue
EP0971624A1 (en) 1997-03-13 2000-01-19 Biomax Technologies, Inc. Methods and apparatus for detecting the rejection of transplanted tissue
US5994690A (en) 1997-03-17 1999-11-30 Kulkarni; Manish D. Image enhancement in optical coherence tomography using deconvolution
GB9707414D0 (en) 1997-04-11 1997-05-28 Imperial College Anatomical probe
EP0979103B1 (en) 1997-04-29 2004-01-02 Amersham Health AS Light imaging contrast agents
JP2001526650A (en) 1997-04-29 2001-12-18 ニユコメド・イメージング・アクシエセルカペト Optical contrast agent
US6117128A (en) 1997-04-30 2000-09-12 Kenton W. Gregory Energy delivery catheter and method for the use thereof
US5887009A (en) 1997-05-22 1999-03-23 Optical Biopsy Technologies, Inc. Confocal optical scanning system employing a fiber laser
US6002480A (en) 1997-06-02 1999-12-14 Izatt; Joseph A. Depth-resolved spectroscopic optical coherence tomography
AU7711498A (en) 1997-06-02 1998-12-21 Joseph A. Izatt Doppler flow imaging using optical coherence tomography
US6208415B1 (en) 1997-06-12 2001-03-27 The Regents Of The University Of California Birefringence imaging in biological tissue using polarization sensitive optical coherent tomography
US5920390A (en) 1997-06-26 1999-07-06 University Of North Carolina Fiberoptic interferometer and associated method for analyzing tissue
US6048349A (en) 1997-07-09 2000-04-11 Intraluminal Therapeutics, Inc. Systems and methods for guiding a medical instrument through a body
US6058352A (en) 1997-07-25 2000-05-02 Physical Optics Corporation Accurate tissue injury assessment using hybrid neural network analysis
US5921926A (en) 1997-07-28 1999-07-13 University Of Central Florida Three dimensional optical imaging colposcopy
US5892583A (en) 1997-08-21 1999-04-06 Li; Ming-Chiang High speed inspection of a sample using superbroad radiation coherent interferometer
US6014214A (en) 1997-08-21 2000-01-11 Li; Ming-Chiang High speed inspection of a sample using coherence processing of scattered superbroad radiation
US6069698A (en) 1997-08-28 2000-05-30 Olympus Optical Co., Ltd. Optical imaging apparatus which radiates a low coherence light beam onto a test object, receives optical information from light scattered by the object, and constructs therefrom a cross-sectional image of the object
US6297018B1 (en) 1998-04-17 2001-10-02 Ljl Biosystems, Inc. Methods and apparatus for detecting nucleic acid polymorphisms
US5876343A (en) * 1997-09-23 1999-03-02 Scimed Life Systems, Inc. Methods and apparatus for blood speckle detection in an intravascular ultrasound imaging system
US5920373A (en) 1997-09-24 1999-07-06 Heidelberg Engineering Optische Messysteme Gmbh Method and apparatus for determining optical characteristics of a cornea
US6193676B1 (en) 1997-10-03 2001-02-27 Intraluminal Therapeutics, Inc. Guide wire assembly
US5951482A (en) 1997-10-03 1999-09-14 Intraluminal Therapeutics, Inc. Assemblies and methods for advancing a guide wire through body tissue
US6091984A (en) 1997-10-10 2000-07-18 Massachusetts Institute Of Technology Measuring tissue morphology
US5955737A (en) 1997-10-27 1999-09-21 Systems & Processes Engineering Corporation Chemometric analysis for extraction of individual fluorescence spectrum and lifetimes from a target mixture
US6134010A (en) 1997-11-07 2000-10-17 Lucid, Inc. Imaging system using polarization effects to enhance image quality
US6165170A (en) 1998-01-29 2000-12-26 International Business Machines Corporation Laser dermablator and dermablation
EP2267507A3 (en) 1998-02-26 2011-08-17 The General Hospital Corporation Confocal microscopy with multi-spectral encoding
US6831781B2 (en) 1998-02-26 2004-12-14 The General Hospital Corporation Confocal microscopy with multi-spectral encoding and system and apparatus for spectroscopically encoded confocal microscopy
US6048742A (en) 1998-02-26 2000-04-11 The United States Of America As Represented By The Secretary Of The Air Force Process for measuring the thickness and composition of thin semiconductor films deposited on semiconductor wafers
US6134033A (en) 1998-02-26 2000-10-17 Tyco Submarine Systems Ltd. Method and apparatus for improving spectral efficiency in wavelength division multiplexed transmission systems
US6066102A (en) 1998-03-09 2000-05-23 Spectrascience, Inc. Optical biopsy forceps system and method of diagnosing tissue
US6174291B1 (en) 1998-03-09 2001-01-16 Spectrascience, Inc. Optical biopsy system and methods for tissue diagnosis
US6151522A (en) 1998-03-16 2000-11-21 The Research Foundation Of Cuny Method and system for examining biological materials using low power CW excitation raman spectroscopy
US6175669B1 (en) 1998-03-30 2001-01-16 The Regents Of The Universtiy Of California Optical coherence domain reflectometry guidewire
DE19814057B4 (en) 1998-03-30 2009-01-02 Carl Zeiss Meditec Ag Arrangement for optical coherence tomography and coherence topography
US6384915B1 (en) 1998-03-30 2002-05-07 The Regents Of The University Of California Catheter guided by optical coherence domain reflectometry
WO1999057507A1 (en) 1998-05-01 1999-11-11 Board Of Regents, The University Of Texas System Method and apparatus for subsurface imaging
JPH11326826A (en) 1998-05-13 1999-11-26 Sony Corp Illuminating method and illuminator
US6053613A (en) 1998-05-15 2000-04-25 Carl Zeiss, Inc. Optical coherence tomography with new interferometer
US5995223A (en) 1998-06-01 1999-11-30 Power; Joan Fleurette Apparatus for rapid phase imaging interferometry and method therefor
US6549801B1 (en) 1998-06-11 2003-04-15 The Regents Of The University Of California Phase-resolved optical coherence tomography and optical doppler tomography for imaging fluid flow in tissue with fast scanning speed and high velocity sensitivity
CA2337113C (en) 1998-07-15 2009-06-23 Corazon Technologies, Inc. Methods and devices for reducing the mineral content of vascular calcified lesions
US6166373A (en) 1998-07-21 2000-12-26 The Institute For Technology Development Focal plane scanner with reciprocating spatial window
WO2000019889A1 (en) 1998-10-08 2000-04-13 University Of Kentucky Research Foundation Methods and apparatus for in vivo identification and characterization of vulnerable atherosclerotic plaques
US6274871B1 (en) 1998-10-22 2001-08-14 Vysis, Inc. Method and system for performing infrared study on a biological sample
US6324419B1 (en) 1998-10-27 2001-11-27 Nejat Guzelsu Apparatus and method for non-invasive measurement of stretch
DE69932485T2 (en) 1998-11-20 2007-01-11 Fuji Photo Film Co. Ltd., Minamiashigara Blood vessel imaging system
US5975697A (en) 1998-11-25 1999-11-02 Oti Ophthalmic Technologies, Inc. Optical mapping apparatus with adjustable depth resolution
US6352502B1 (en) 1998-12-03 2002-03-05 Lightouch Medical, Inc. Methods for obtaining enhanced spectroscopic information from living tissue, noninvasive assessment of skin condition and detection of skin abnormalities
US6191862B1 (en) 1999-01-20 2001-02-20 Lightlab Imaging, Llc Methods and apparatus for high speed longitudinal scanning in imaging systems
US6272376B1 (en) 1999-01-22 2001-08-07 Cedars-Sinai Medical Center Time-resolved, laser-induced fluorescence for the characterization of organic material
US6445944B1 (en) 1999-02-01 2002-09-03 Scimed Life Systems Medical scanning system and related method of scanning
US6615072B1 (en) 1999-02-04 2003-09-02 Olympus Optical Co., Ltd. Optical imaging device
US6185271B1 (en) 1999-02-16 2001-02-06 Richard Estyn Kinsinger Helical computed tomography with feedback scan control
DE19908883A1 (en) 1999-03-02 2000-09-07 Rainer Heintzmann Process for increasing the resolution of optical imaging
JP4932993B2 (en) 1999-03-29 2012-05-16 ボストン サイエンティフィック サイムド,インコーポレイテッド Single mode fiber optic coupling system
US6859275B2 (en) 1999-04-09 2005-02-22 Plain Sight Systems, Inc. System and method for encoded spatio-spectral information processing
US6264610B1 (en) 1999-05-05 2001-07-24 The University Of Connecticut Combined ultrasound and near infrared diffused light imaging system
US6353693B1 (en) 1999-05-31 2002-03-05 Sanyo Electric Co., Ltd. Optical communication device and slip ring unit for an electronic component-mounting apparatus
US6208887B1 (en) 1999-06-24 2001-03-27 Richard H. Clarke Catheter-delivered low resolution Raman scattering analyzing system for detecting lesions
US7426409B2 (en) 1999-06-25 2008-09-16 Board Of Regents, The University Of Texas System Method and apparatus for detecting vulnerable atherosclerotic plaque
GB9915082D0 (en) 1999-06-28 1999-08-25 Univ London Optical fibre probe
US6359692B1 (en) 1999-07-09 2002-03-19 Zygo Corporation Method and system for profiling objects having multiple reflective surfaces using wavelength-tuning phase-shifting interferometry
ES2279767T3 (en) 1999-07-30 2007-09-01 Ceramoptec Gmbh DOUBLE LENGTH MEDICAL DIODE LASER SYSTEM.
ES2242622T3 (en) 1999-07-30 2005-11-16 Boston Scientific Limited CONNECTION OF ROTATIONAL AND TRANSLATION PROPULSION FOR CATETER ASSEMBLY.
JP2001046321A (en) 1999-08-09 2001-02-20 Asahi Optical Co Ltd Endoscope device
JP3869589B2 (en) 1999-09-02 2007-01-17 ペンタックス株式会社 Fiber bundle and endoscope apparatus
US6687010B1 (en) 1999-09-09 2004-02-03 Olympus Corporation Rapid depth scanning optical imaging device
US6198956B1 (en) 1999-09-30 2001-03-06 Oti Ophthalmic Technologies Inc. High speed sector scanning apparatus having digital electronic control
US6393312B1 (en) 1999-10-13 2002-05-21 C. R. Bard, Inc. Connector for coupling an optical fiber tissue localization device to a light source
US6308092B1 (en) 1999-10-13 2001-10-23 C. R. Bard Inc. Optical fiber tissue localization device
AU1182401A (en) 1999-10-15 2001-04-23 Cellavision Ab Microscope and method for manufacturing a composite image with a high resolution
US6538817B1 (en) 1999-10-25 2003-03-25 Aculight Corporation Method and apparatus for optical coherence tomography with a multispectral laser source
JP2001125009A (en) 1999-10-28 2001-05-11 Asahi Optical Co Ltd Endoscope
ATE263356T1 (en) 1999-11-24 2004-04-15 Haag Ag Streit METHOD AND DEVICE FOR MEASURING OPTICAL PROPERTIES OF AT LEAST TWO DISTANCED AREAS IN A TRANSPARENT AND/OR DIFFUSIVE OBJECT
US7236637B2 (en) 1999-11-24 2007-06-26 Ge Medical Systems Information Technologies, Inc. Method and apparatus for transmission and display of a compressed digitized image
JP2003516531A (en) 1999-12-09 2003-05-13 オーティーアイ オフサルミック テクノロジーズ インク Optical mapping device with variable depth resolution
US6738144B1 (en) 1999-12-17 2004-05-18 University Of Central Florida Non-invasive method and low-coherence apparatus system analysis and process control
US6680780B1 (en) 1999-12-23 2004-01-20 Agere Systems, Inc. Interferometric probe stabilization relative to subject movement
US6445485B1 (en) 2000-01-21 2002-09-03 At&T Corp. Micro-machine polarization-state controller
US7860554B2 (en) 2000-01-27 2010-12-28 National Research Council Of Canada Visible-near infrared spectroscopy in burn injury assessment
US6475210B1 (en) 2000-02-11 2002-11-05 Medventure Technology Corp Light treatment of vulnerable atherosclerosis plaque
US6556305B1 (en) 2000-02-17 2003-04-29 Veeco Instruments, Inc. Pulsed source scanning interferometer
US6751490B2 (en) 2000-03-01 2004-06-15 The Board Of Regents Of The University Of Texas System Continuous optoacoustic monitoring of hemoglobin concentration and hematocrit
US6687013B2 (en) 2000-03-28 2004-02-03 Hitachi, Ltd. Laser interferometer displacement measuring system, exposure apparatus, and electron beam lithography apparatus
US6567585B2 (en) 2000-04-04 2003-05-20 Optiscan Pty Ltd Z sharpening for fibre confocal microscopes
US6889075B2 (en) 2000-05-03 2005-05-03 Rocky Mountain Biosystems, Inc. Optical imaging of subsurface anatomical structures and biomolecules
JP4460117B2 (en) 2000-06-29 2010-05-12 独立行政法人理化学研究所 Grism
US6757467B1 (en) 2000-07-25 2004-06-29 Optical Air Data Systems, Lp Optical fiber system
US6882432B2 (en) 2000-08-08 2005-04-19 Zygo Corporation Frequency transform phase shifting interferometry
AU2001279603A1 (en) 2000-08-11 2002-02-25 Crystal Fibre A/S Optical wavelength converter
US7625335B2 (en) 2000-08-25 2009-12-01 3Shape Aps Method and apparatus for three-dimensional optical scanning of interior surfaces
AU2001288320A1 (en) 2000-09-05 2002-03-22 Arroyo Optics, Inc. System and method for fabricating components of precise optical path length
JP3842101B2 (en) 2000-10-31 2006-11-08 富士写真フイルム株式会社 Endoscope device
US6687036B2 (en) 2000-11-03 2004-02-03 Nuonics, Inc. Multiplexed optical scanner technology
US9295391B1 (en) 2000-11-10 2016-03-29 The General Hospital Corporation Spectrally encoded miniature endoscopic imaging probe
WO2002038806A2 (en) 2000-11-13 2002-05-16 Gnothis Holding Sa Detection of nucleic acid polymorphisms
US6665075B2 (en) 2000-11-14 2003-12-16 Wm. Marshurice University Interferometric imaging system and method
DE10057539B4 (en) 2000-11-20 2008-06-12 Robert Bosch Gmbh Interferometric measuring device
US6558324B1 (en) 2000-11-22 2003-05-06 Siemens Medical Solutions, Inc., Usa System and method for strain image display
US6856712B2 (en) 2000-11-27 2005-02-15 University Of Washington Micro-fabricated optical waveguide for use in scanning fiber displays and scanned fiber image acquisition
JP4786027B2 (en) 2000-12-08 2011-10-05 オリンパス株式会社 Optical system and optical apparatus
US6501878B2 (en) 2000-12-14 2002-12-31 Nortel Networks Limited Optical fiber termination
US6687007B1 (en) 2000-12-14 2004-02-03 Kestrel Corporation Common path interferometer for spectral image generation
US6515752B2 (en) 2000-12-28 2003-02-04 Coretek, Inc. Wavelength monitoring system
ES2274915T3 (en) 2000-12-28 2007-06-01 Palomar Medical Technologies, Inc. ELECTROMAGNETIC RADIATION TREATMENT DEVICE (EMR) OF THE SKIN.
CA2433797A1 (en) 2001-01-11 2002-07-18 The Johns Hopkins University Assessment of tooth structure using laser based ultrasonics
US7177491B2 (en) 2001-01-12 2007-02-13 Board Of Regents The University Of Texas System Fiber-based optical low coherence tomography
EP1358443A2 (en) 2001-01-22 2003-11-05 Jonathan E. Roth Method and apparatus for polarization-sensitive optical coherence tomography
US20020140942A1 (en) 2001-02-17 2002-10-03 Fee Michale Sean Acousto-optic monitoring and imaging in a depth sensitive manner
US6721094B1 (en) 2001-03-05 2004-04-13 Sandia Corporation Long working distance interference microscope
US6563995B2 (en) 2001-04-02 2003-05-13 Lightwave Electronics Optical wavelength filtering apparatus with depressed-index claddings
US6552796B2 (en) 2001-04-06 2003-04-22 Lightlab Imaging, Llc Apparatus and method for selective data collection and signal to noise ratio enhancement using optical coherence tomography
US20020158211A1 (en) 2001-04-16 2002-10-31 Dakota Technologies, Inc. Multi-dimensional fluorescence apparatus and method for rapid and highly sensitive quantitative analysis of mixtures
DE10118760A1 (en) 2001-04-17 2002-10-31 Med Laserzentrum Luebeck Gmbh Procedure for determining the runtime distribution and arrangement
JP2004528111A (en) 2001-04-30 2004-09-16 ザ・ジェネラル・ホスピタル・コーポレイション Method and apparatus for improving image clarity and sensitivity in optical interference tomography using dynamic feedback to control focus characteristics and coherence gate
US7616986B2 (en) 2001-05-07 2009-11-10 University Of Washington Optical fiber scanner for performing multimodal optical imaging
US6615062B2 (en) 2001-05-31 2003-09-02 Infraredx, Inc. Referencing optical catheters
US6701181B2 (en) 2001-05-31 2004-03-02 Infraredx, Inc. Multi-path optical catheter
DE60219627T2 (en) 2001-06-04 2008-02-07 The General Hospital Corp., Boston IDENTIFICATION AND THERAPY OF SENSITIVE PLAQUE WITH PHOTODYNAMIC COMPOUNDS
US6879851B2 (en) 2001-06-07 2005-04-12 Lightlab Imaging, Llc Fiber optic endoscopic gastrointestinal probe
US6702744B2 (en) 2001-06-20 2004-03-09 Advanced Cardiovascular Systems, Inc. Agents that stimulate therapeutic angiogenesis and techniques and devices that enable their delivery
US20040166593A1 (en) 2001-06-22 2004-08-26 Nolte David D. Adaptive interferometric multi-analyte high-speed biosensor
US6685885B2 (en) 2001-06-22 2004-02-03 Purdue Research Foundation Bio-optical compact dist system
DE10137530A1 (en) 2001-08-01 2003-02-13 Presens Prec Sensing Gmbh Arrangement and method for multiple fluorescence measurement
AU2002337666A1 (en) 2001-08-03 2003-02-17 Joseph A. Izatt Aspects of basic oct engine technologies for high speed optical coherence tomography and light source and other improvements in oct
US20030030816A1 (en) 2001-08-11 2003-02-13 Eom Tae Bong Nonlinearity error correcting method and phase angle measuring method for displacement measurement in two-freqency laser interferometer and displacement measurement system using the same
US20030045798A1 (en) 2001-09-04 2003-03-06 Richard Hular Multisensor probe for tissue identification
US6961123B1 (en) 2001-09-28 2005-11-01 The Texas A&M University System Method and apparatus for obtaining information from polarization-sensitive optical coherence tomography
US6980299B1 (en) 2001-10-16 2005-12-27 General Hospital Corporation Systems and methods for imaging a sample
US7006231B2 (en) 2001-10-18 2006-02-28 Scimed Life Systems, Inc. Diffraction grating based interferometric systems and methods
US7239399B2 (en) * 2001-11-13 2007-07-03 Cyberoptics Corporation Pick and place machine with component placement inspection
US6661513B1 (en) 2001-11-21 2003-12-09 Roygbiv, Llc Refractive-diffractive spectrometer
US20030216719A1 (en) 2001-12-12 2003-11-20 Len Debenedictis Method and apparatus for treating skin using patterns of optical energy
US7736301B1 (en) 2001-12-18 2010-06-15 Advanced Cardiovascular Systems, Inc. Rotatable ferrules and interfaces for use with an optical guidewire
US7365858B2 (en) 2001-12-18 2008-04-29 Massachusetts Institute Of Technology Systems and methods for phase measurements
US6947787B2 (en) 2001-12-21 2005-09-20 Advanced Cardiovascular Systems, Inc. System and methods for imaging within a body lumen
US6975891B2 (en) 2001-12-21 2005-12-13 Nir Diagnostics Inc. Raman spectroscopic system with integrating cavity
EP1324051A1 (en) 2001-12-26 2003-07-02 Kevin R. Forrester Motion measuring device
US7072045B2 (en) 2002-01-16 2006-07-04 The Regents Of The University Of California High resolution optical coherence tomography with an improved depth range using an axicon lens
ATE541202T1 (en) 2002-01-24 2012-01-15 Gen Hospital Corp DEVICE AND METHOD FOR LOCATION AND REDUCTION OF NOISE OF SIGNALS IN LOW COHERENCE INTERFEROMETRY (LCI) AND OPTICAL COHERENCE TOMOGRAPHY (OCT) USING PARALLEL DETECTION OF SPECTRAL BANDS
US7355716B2 (en) 2002-01-24 2008-04-08 The General Hospital Corporation Apparatus and method for ranging and noise reduction of low coherence interferometry LCI and optical coherence tomography OCT signals by parallel detection of spectral bands
EP1475606A4 (en) 2002-02-14 2007-04-04 Imalux Corp Method for studying an object and an optical interferometer for carrying out said method
US7116887B2 (en) 2002-03-19 2006-10-03 Nufern Optical fiber
US7113818B2 (en) 2002-04-08 2006-09-26 Oti Ophthalmic Technologies Inc. Apparatus for high resolution imaging of moving organs
US7016048B2 (en) 2002-04-09 2006-03-21 The Regents Of The University Of California Phase-resolved functional optical coherence tomography: simultaneous imaging of the stokes vectors, structure, blood flow velocity, standard deviation and birefringence in biological samples
US20030236443A1 (en) 2002-04-19 2003-12-25 Cespedes Eduardo Ignacio Methods and apparatus for the identification and stabilization of vulnerable plaque
US7503904B2 (en) 2002-04-25 2009-03-17 Cardiac Pacemakers, Inc. Dual balloon telescoping guiding catheter
JP4135551B2 (en) 2002-05-07 2008-08-20 松下電工株式会社 Position sensor
AU2003245458A1 (en) 2002-06-12 2003-12-31 Advanced Research And Technology Institute, Inc. Method and apparatus for improving both lateral and axial resolution in ophthalmoscopy
US7283247B2 (en) 2002-09-25 2007-10-16 Olympus Corporation Optical probe system
US6842254B2 (en) 2002-10-16 2005-01-11 Fiso Technologies Inc. System and method for measuring an optical path difference in a sensing interferometer
WO2004034869A2 (en) 2002-10-18 2004-04-29 Arieh Sher Atherectomy system with imaging guidewire
US6847449B2 (en) 2002-11-27 2005-01-25 The United States Of America As Represented By The Secretary Of The Navy Method and apparatus for reducing speckle in optical coherence tomography images
EP1426799A3 (en) 2002-11-29 2005-05-18 Matsushita Electric Industrial Co., Ltd. Optical demultiplexer, optical multi-/demultiplexer, and optical device
DE10260256B9 (en) 2002-12-20 2007-03-01 Carl Zeiss Interferometer system and measuring / machining tool
JP4148771B2 (en) 2002-12-27 2008-09-10 株式会社トプコン Laser device for medical machine
US7123363B2 (en) 2003-01-03 2006-10-17 Rose-Hulman Institute Of Technology Speckle pattern analysis method and system
WO2004066824A2 (en) 2003-01-24 2004-08-12 The General Hospital Corporation System and method for identifying tissue using low-coherence interferometry
US6943892B2 (en) 2003-01-29 2005-09-13 Sarnoff Corporation Instrument having a multi-mode optical element and method
JP4338412B2 (en) 2003-02-24 2009-10-07 Hoya株式会社 Confocal probe and confocal microscope
CA2519937C (en) 2003-03-31 2012-11-20 Guillermo J. Tearney Speckle reduction in optical coherence tomography by path length encoded angular compounding
JP4135550B2 (en) 2003-04-18 2008-08-20 日立電線株式会社 Semiconductor light emitting device
US7110109B2 (en) 2003-04-18 2006-09-19 Ahura Corporation Raman spectroscopy system and method and specimen holder therefor
US7347548B2 (en) 2003-05-01 2008-03-25 The Cleveland Clinic Foundation Method and apparatus for measuring a retinal sublayer characteristic
WO2004100068A2 (en) 2003-05-05 2004-11-18 D3D, L.P. Optical coherence tomography imaging
US7376455B2 (en) 2003-05-22 2008-05-20 Scimed Life Systems, Inc. Systems and methods for dynamic optical imaging
WO2004111929A2 (en) 2003-05-28 2004-12-23 Duke University Improved system for fourier domain optical coherence tomography
WO2004111661A2 (en) 2003-05-30 2004-12-23 Duke University System and method for low coherence broadband quadrature interferometry
US7263394B2 (en) 2003-06-04 2007-08-28 Tomophase Corporation Coherence-gated optical glucose monitor
US6943881B2 (en) 2003-06-04 2005-09-13 Tomophase Corporation Measurements of optical inhomogeneity and other properties in substances using propagation modes of light
EP2011434A3 (en) 2003-06-06 2009-03-25 The General Hospital Corporation Process and apparatus for a wavelength tuned light source
US20040260182A1 (en) 2003-06-23 2004-12-23 Zuluaga Andres F. Intraluminal spectroscope with wall contacting probe
US20050083534A1 (en) 2003-08-28 2005-04-21 Riza Nabeel A. Agile high sensitivity optical sensor
JP2005077964A (en) 2003-09-03 2005-03-24 Fujitsu Ltd Spectroscope apparatus
US20050057680A1 (en) 2003-09-16 2005-03-17 Agan Martin J. Method and apparatus for controlling integration time in imagers
US6949072B2 (en) 2003-09-22 2005-09-27 Infraredx, Inc. Devices for vulnerable plaque detection
US7142835B2 (en) 2003-09-29 2006-11-28 Silicon Laboratories, Inc. Apparatus and method for digital image correction in a receiver
KR101384553B1 (en) 2003-10-27 2014-04-11 더 제너럴 하스피탈 코포레이션 Method and apparatus for performing optical imaging using frequency-domain interferometry
DE10351319B4 (en) 2003-10-31 2005-10-20 Med Laserzentrum Luebeck Gmbh Interferometer for optical coherence tomography
US7130320B2 (en) 2003-11-13 2006-10-31 Mitutoyo Corporation External cavity laser with rotary tuning element
JP5214883B2 (en) 2003-11-28 2013-06-19 ザ ジェネラル ホスピタル コーポレイション Method and apparatus for three-dimensional spectrally encoded imaging
US7359062B2 (en) 2003-12-09 2008-04-15 The Regents Of The University Of California High speed spectral domain functional optical coherence tomography and optical doppler tomography for in vivo blood flow dynamics and tissue structure
DE10358735B4 (en) 2003-12-15 2011-04-21 Siemens Ag Catheter device comprising a catheter, in particular an intravascular catheter
US7145661B2 (en) 2003-12-31 2006-12-05 Carl Zeiss Meditec, Inc. Efficient optical coherence tomography (OCT) system and method for rapid imaging in three dimensions
WO2005082225A1 (en) 2004-02-27 2005-09-09 Optiscan Pty Ltd Optical element
US7242480B2 (en) 2004-05-14 2007-07-10 Medeikon Corporation Low coherence interferometry for detecting and characterizing plaques
US7190464B2 (en) 2004-05-14 2007-03-13 Medeikon Corporation Low coherence interferometry for detecting and characterizing plaques
AU2005270037B2 (en) 2004-07-02 2012-02-09 The General Hospital Corporation Endoscopic imaging probe comprising dual clad fibre
US7366376B2 (en) 2004-09-29 2008-04-29 The General Hospital Corporation System and method for optical coherence imaging
US7382949B2 (en) 2004-11-02 2008-06-03 The General Hospital Corporation Fiber-optic rotational device, optical system and method for imaging a sample
US7417740B2 (en) 2004-11-12 2008-08-26 Medeikon Corporation Single trace multi-channel low coherence interferometric sensor
WO2006058187A2 (en) 2004-11-23 2006-06-01 Robert Eric Betzig Optical lattice microscopy
GB0426609D0 (en) 2004-12-03 2005-01-05 Ic Innovations Ltd Analysis
JP2006162366A (en) 2004-12-06 2006-06-22 Fujinon Corp Optical tomographic imaging system
US7450242B2 (en) 2004-12-10 2008-11-11 Fujifilm Corporation Optical tomography apparatus
US7336366B2 (en) 2005-01-20 2008-02-26 Duke University Methods and systems for reducing complex conjugate ambiguity in interferometric data
US7267494B2 (en) 2005-02-01 2007-09-11 Finisar Corporation Fiber stub for cladding mode coupling reduction
US7860555B2 (en) 2005-02-02 2010-12-28 Voyage Medical, Inc. Tissue visualization and manipulation system
JP4628820B2 (en) 2005-02-25 2011-02-09 サンテック株式会社 Wavelength scanning fiber laser light source
JP2008541096A (en) 2005-05-13 2008-11-20 ザ ジェネラル ホスピタル コーポレイション Apparatus, system, and method capable of performing spectral domain optical coherence reflectometry for sensitive detection of chemical and biological samples
WO2006130797A2 (en) 2005-05-31 2006-12-07 The General Hospital Corporation Spectral encoding heterodyne interferometry techniques for imaging
US7391520B2 (en) 2005-07-01 2008-06-24 Carl Zeiss Meditec, Inc. Fourier domain optical coherence tomography employing a swept multi-wavelength laser and a multi-channel receiver
JP4376837B2 (en) 2005-08-05 2009-12-02 サンテック株式会社 Wavelength scanning laser light source
US7668342B2 (en) 2005-09-09 2010-02-23 Carl Zeiss Meditec, Inc. Method of bioimage data processing for revealing more meaningful anatomic features of diseased tissues
KR100743591B1 (en) 2005-09-23 2007-07-27 한국과학기술원 Confocal Self-Interference Microscopy Which Excluding Side Lobes
JP5371433B2 (en) 2005-09-29 2013-12-18 ザ ジェネラル ホスピタル コーポレイション Optical imaging method and apparatus by spectral coding
US7636168B2 (en) 2005-10-11 2009-12-22 Zygo Corporation Interferometry method and system including spectral decomposition
EP2950065A1 (en) 2005-10-11 2015-12-02 Duke University Method for fiber-based endoscopic angle-resolved low coherence interferometry
DK1973466T3 (en) 2006-01-19 2021-02-01 Massachusetts Gen Hospital BALLOON IMAGING CATHETER
WO2007084945A1 (en) 2006-01-19 2007-07-26 The General Hospital Corporation Systems and methods for performing rapid fluorescense lifetime, excitation and emission spectral measurements
GB0601183D0 (en) 2006-01-20 2006-03-01 Perkinelmer Ltd Improvements in and relating to imaging
JP2007271761A (en) 2006-03-30 2007-10-18 Fujitsu Ltd Spectrometer and wavelength dispersion controller
US7599074B2 (en) 2006-06-19 2009-10-06 The Board Of Trustees Of The Leland Stanford Junior University Grating angle magnification enhanced angular sensor and scanner
US20070291277A1 (en) 2006-06-20 2007-12-20 Everett Matthew J Spectral domain optical coherence tomography system
US7496220B2 (en) 2006-08-28 2009-02-24 Thermo Electron Scientific Instruments Llc Spectroscopic microscopy with image-driven analysis
ES2401724T3 (en) 2007-03-26 2013-04-24 National University Corporation Tokyo University Of Marine Science And Technology Germ cell marker that uses the Vasa fish gene
US20100277716A1 (en) * 2007-11-09 2010-11-04 CiDRA Corporated Services Inc. Non-contact optical flow measurements

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036015A1 (en) * 2000-10-30 2002-05-10 The General Hospital Corporation Optical methods and systems for tissue analysis
US20040068163A1 (en) * 2001-01-26 2004-04-08 Ruchti Timothy L. Noninvasive measurement of glucose through the optical properties of tissue
US7365859B2 (en) * 2004-09-10 2008-04-29 The General Hospital Corporation System and method for optical coherence imaging
WO2008121844A1 (en) * 2007-03-30 2008-10-09 The General Hospital Corporation System and method providing intracoronary laser speckle imaging for the detection of vulnerable plaque

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10390729B2 (en) 2011-01-28 2019-08-27 Bar Ilan University Method and system for non-invasively monitoring biological or biochemical parameters of individual
US11129544B2 (en) 2011-01-28 2021-09-28 Bar Ilan University Method and system for non-invasively monitoring biological or biochemical parameters of individual
CN106061373A (en) * 2011-01-28 2016-10-26 巴伊兰大学 Method and system for non-invasively monitoring biological or biochemical parameters of individual
US9636041B2 (en) 2011-01-28 2017-05-02 Bar Ilan University Method and system for non-invasively monitoring biological or biochemical parameters of individual
US9668672B2 (en) 2011-01-28 2017-06-06 Bar Ilan University Method and system for non-invasively monitoring biological or biochemical parameters of individual
WO2012101644A3 (en) * 2011-01-28 2012-11-01 Bar Ilan University Method and system for non-invasively monitoring biological or biochemical parameters of individual
EP2676123A4 (en) * 2011-02-18 2016-01-20 Gen Hospital Corp Laser speckle microrheometer for measuring mechanical properties of biological tissue
US11026594B2 (en) 2012-05-14 2021-06-08 Intuitive Surgical Operations, Inc. Systems and methods for deformation compensation using shape sensing
CN108542499B (en) * 2012-05-14 2020-12-04 直观外科手术操作公司 Systems and methods for deformation compensation using shape sensing
CN108542499A (en) * 2012-05-14 2018-09-18 直观外科手术操作公司 Deformation-compensated system and method for using shape to sense
US11678813B2 (en) 2012-05-14 2023-06-20 Intuitive Surgical Operations, Inc. Systems and methods for deformation compensation using shape sensing
US10398314B2 (en) 2012-08-01 2019-09-03 Bar Ilan University Method and system for non-invasively monitoring biological or biochemical parameters of individual
US20150305681A1 (en) * 2012-12-19 2015-10-29 The General Hospital Corporation Optical Blood-Coagulation Sensor
US11172888B2 (en) * 2012-12-19 2021-11-16 The General Hospital Corporation Optical blood-coagulation sensor
CN112740015A (en) * 2019-02-28 2021-04-30 地方独立行政法人神奈川县立产业技术综合研究所 Fluid sample internal structure observation device and internal structure analysis system, fluid sample internal structure observation method and internal structure analysis method, and ceramic manufacturing method
CN111981997A (en) * 2020-07-21 2020-11-24 广东工业大学 PS-OCT strain estimation method based on large deformation
CN111981997B (en) * 2020-07-21 2022-01-28 广东工业大学 PS-OCT strain estimation method based on large deformation

Also Published As

Publication number Publication date
US9351642B2 (en) 2016-05-31
US20120130253A1 (en) 2012-05-24
WO2010105197A3 (en) 2011-01-13

Similar Documents

Publication Publication Date Title
US9351642B2 (en) Non-contact optical system, computer-accessible medium and method for measurement at least one mechanical property of tissue using coherent speckle technique(s)
JP7410212B2 (en) Apparatus, device and method for obtaining omnidirectional viewing by catheter
Nadkarni et al. Characterization of atherosclerotic plaques by laser speckle imaging
Niestrawska et al. Microstructure and mechanics of healthy and aneurysmatic abdominal aortas: experimental analysis and modelling
Kennedy et al. Quantitative micro-elastography: imaging of tissue elasticity using compression optical coherence elastography
Rogowska et al. Optical coherence tomographic elastography technique for measuring deformation and strain of atherosclerotic tissues
Fu et al. Elastic stiffness characterization using three-dimensional full-field deformation obtained with optical coherence tomography and digital volume correlation
Nadkarni et al. Measurement of fibrous cap thickness in atherosclerotic plaques by spatiotemporal analysis of laser speckle images
Kirkpatrick et al. OCT-based elastography for large and small deformations
Kennedy et al. Analysis of mechanical contrast in optical coherence elastography
TW201803521A (en) Skin diagnosing apparatus, method of outputting skin state, program and recording media
Singh et al. Optical coherence elastography for evaluating customized riboflavin/UV-A corneal collagen crosslinking
Srivastava et al. Determination of elastic properties of resected human breast tissue samples using optical coherence tomographic elastography
Es’ haghian et al. Optical palpation in vivo: imaging human skin lesions using mechanical contrast
Klyen et al. Identification of muscle necrosis in the mdx mouse model of Duchenne muscular dystrophy using three-dimensional optical coherence tomography
Nebelung et al. Three‐dimensional imaging and analysis of human cartilage degeneration using Optical Coherence Tomography
Hajjarian et al. Tutorial on laser speckle rheology: technology, applications, and opportunities
WO2017139774A1 (en) Laser speckle micro-rheology in characterization of biomechanical properties of tissues
Tschaikowsky et al. Proof-of-concept for the detection of early osteoarthritis pathology by clinically applicable endomicroscopy and quantitative AI-supported optical biopsy
Lenton et al. Clinical cross-polarization optical coherence tomography assessment of subsurface enamel below dental resin composite restorations
Palma-Chavez et al. Review of consensus test methods in medical imaging and current practices in photoacoustic image quality assessment
Flueraru et al. Added soft tissue contrast using signal attenuation and the fractal dimension for optical coherence tomography images of porcine arterial tissue
Patel et al. Monitoring osteoarthritis in the rat model using optical coherence tomography
O'Malley et al. Arthroscopic optical coherence tomography in diagnosis of early arthritis
Castro et al. Nondestructive testing of native and tissue-engineered medical products: adding numbers to pictures

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10751496

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10751496

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 13256175

Country of ref document: US